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ABSTRACT

Designing Predictive Mathematical Models for the Metabolic Pathways
Associated with Polyhydroxybutyrate Synthesis in Escherichia coli
by

Angela Dixon, Master of Science
Utah State University, 2011

Major Professor: Dean H. Scott Hinton
Department: Biological Engineering

Polyhydroxybutyrate (PHB) is a polyhydroxyalkanoate that has been extensively
studied as a potential biodegradable replacement for petrochemically derived plastics.
The synthesis pathway of PHB is native to Ralstonia eutropha, but the genes for the PHB
pathway have successfully been introduced into Escherichia coli through plasmids such
as the pBHR68 plasmid. However, the production of PHB needs to be more costeffective before it can be commercially produced.
A mathematical model for PHB synthesis was developed to identify target genes
that could be genetically engineered to increase PHB production. The major metabolic
pathways included in the model were glycolysis, acetyl coenzyme A (acetyl-CoA)
synthesis, tricarboxylic acid (TCA) cycle, glyoxylate bypass, and PHB synthesis. Each
reaction in the selected metabolic pathways was modeled using the kinetic mechanism
identified for the associated enzyme. The promoters and transcription factors for each
enzyme were incorporated into the model. The model was validated through comparison
with other published models and experimental PHB production data.

iii
The predictive model identified 16 enzymes as having no effect on PHB
production, 5 enzymes with a slight effect on PHB production, and 9 enzymes with large
effects on PHB production. Decreasing the substrate affinity of the enzyme citrate
synthase resulted in the largest increase in PHB synthesis. The second largest increase
was observed from lowering the substrate affinity of glyceraldehyde-3-phosphate
dehydrogenase. The predictive model also indicated that increasing the activity of the lac
promoter in the pBHR68 plasmid resulted in the largest increase in the rate of PHB
production.
The predictive model successfully identified two genes and one promoter as
targets for genetic engineering to create an optimized strain of E. coli for PHB
production. The substrate-binding sites for the genes gltA (citrate synthase) and gapA
(glyceraldehyde-3-phosphate dehydrogenase) should be genetically engineered to be less
effective at binding the substrates. The lac promoter in the pBHR68 plasmid should be
genetically engineered to more closely match the consensus sequence for binding to RNA
polymerase. The model predicts that an optimized strain of E. coli for PHB production
could be achieved by genetically altering gltA, gapA, and the lac promoter.
(198 pages)
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PUBLIC ABSTRACT

Designing Predictive Mathematical Models for the Metabolic Pathways
Associated with Polyhydroxybutyrate Synthesis in Escherichia coli
by

Angela Dixon

Plastics are a versatile and widely used material. However, traditional plastics are
derived from petrochemicals and are not biodegradable. Polymers synthesized from
microorganisms that have similar properties to plastic are potential biodegradable
replacements. The objective of this project is to use mathematical modeling as a tool to
engineer a strain of bacteria optimized for the production of bio-plastics.
Production costs can be reduced by using a bacterial strain specifically optimized
for bio-plastic production. By reducing production costs, bio-plastics will be able to
commercially compete with traditional plastics. Society will benefit as bio-plastics
replace traditional plastics. Fossil fuels will not be depleted by the production of
traditional plastics, and the bio-plastics will biodegrade in landfills.
The costs of this research are nominal. Developing a model takes only time and
minimal laboratory work. An effective predictive model will reduce laboratory time and
cost because it will indicate how to efficiently engineer a microorganism strain optimized
for the production of bio-plastics. This design process can also be used to develop
predictive models for the production of other bioproducts such as biofuels, biomaterials,
and biopharmaceuticals.
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INTRODUCTION

Need for Study

Plastic is one of the most heavily used compounds in the United States.
Traditional plastics are versatile in use and have low production costs. However, they are
produced from non-renewable petrochemicals that are not biodegradable (Reddy et al,
2003). A sustainable alternative is needed in order to decrease both the use of nonrenewable fossil fuels and the buildup of plastic in landfills (Reddy et al, 2003).
Polyhydroxybutyrate (PHB) is a polyhydroxyalkanoate that has been extensively
studied as a potential biodegradable replacement for petrochemical plastics (Byrom,
1987). Polyhydroxyalkanoates are storage material for many gram-positive and gramnegative bacteria (Choi & Lee, 1999). The bio-plastic is created and stored intracellularly
as a reserve of carbon, energy, and reducing power during periods of stress or nutrient
limitation (Doi, 1990; Lee, 1996; Madison & Huisman, 1999). The polymerization of the
soluble nutrients into insoluble compounds prevents leakage out of the cell. This process
allows the bacteria to have continued access to nutrients at a low maintenance cost.
Many bacteria, such as Zoogloea ramigera (Madison & Huisman, 1999; Ploux et
al, 1988) and Ralstonia eutropha (Haywood et al, 1988; Haywood et al, 1989; Madison
& Huisman, 1999; Slater et al, 1998; Steinbüchel & Schlegel, 1991), are capable of
producing and degrading PHB and other polyhydroxyalkanoates. Genes for PHB
synthesis can be cloned into other bacteria such as Escherichia coli. One of the
advantages of using E. coli for the production of PHB is because E. coli is unable to
degrade PHB into soluble compounds (Madison & Huisman, 1999).
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The production of PHB, or any polyhydroxyalkanoate, is costly due to its carbon
source and downstream processing costs (Gurieff & Lant, 2007). The high cost of $2.655/kg is the main reason for the limited application of these bio-plastics (Choi & Lee,
1997; Choi & Lee, 1999). Further studies are needed to help make PHB production more
cost-effective before it can be commercially produced.
Metabolic modeling is a tool that has been used to determine rate-limiting steps
and conditions of PHB production. However, metabolic models have focused solely on
the three enzymes in the PHB synthesis pathway and have neglected to account for other
key pathways in the cell (Leaf & Srienc, 1998; Van Wegen et al, 1998; Van Wegen et al,
2001). Models have also failed to account for the transcriptional network that is essential
in understanding how enzymes of interest are regulated. Most models focus on
optimizing the culturing methods to improve PHB production, but seldom address the
possibility of optimizing the prokaryotic strain (Choi & Lee, 1997; Choi & Lee, 1999;
Jurasek & Marchessault, 2004; Leaf & Srienc, 1998; Mantzaris et al, 2002; Shang et al,
2007; Van Wegen et al, 1998; Van Wegen et al, 2001).
A predictive model of the metabolic pathways of the cell should be able to
quantitatively predict how changes in one pathway can affect the synthesis rate of a
product of interest. This approach would require the predictive model to account for the
complex metabolic pathways present in a cell. A model that focuses on one metabolic
pathway lacks valuable information on what is happening elsewhere in the cell. A more
complex model that accounts for many metabolic pathways and their transcriptional
networks could be used as a guide in the laboratory for engineering optimized
prokaryotic factories. Utilizing the synthetic biology toolbox, a strain of E. coli with its
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metabolic pathways optimized for the synthesis of a single product could be engineered.
The predictive model will allow one to target specific enzymes, promoters, or
transcription factors out of many metabolic pathways for genetic engineering.
A model encompassing the major metabolic pathways associated with PHB
synthesis will help determine the amount of energy and reducing power that can be
diverted into the PHB synthesis pathway for the optimal PHB production. The major
pathways involved in PHB synthesis that are included in the model are glycolysis, acetyl
coenzyme A (acetyl-CoA) synthesis, tricarboxylic acid cycle (TCA), glyoxylate shunt,
and PHB synthesis (Madison & Huisman, 1999). The model must effectively simulate the
individual reactions in the previously mentioned pathways. Kinetic mechanisms, kinetic
parameters, genes, and transcription factors must be determined for each reaction. Events
and rules can simulate conditions that trigger the regulation of each enzyme to simulate in
vivo conditions.
Flux balance analysis (FBA) is a tool currently used to model genome-scale
metabolic networks. FBA is a constraint approach that focuses on stoichiometric
information rather than kinetic data. Stoichiometric data is more widely available than
kinetic data for different reactions and organisms. However, the kinetic data needed to
build a genome-scale mechanistic model will become available as technology advances
the collection of high throughput metabolomic data (Jamshidi & Palsson, 2008). Models
based on FBA can be used to predict outcomes of gene deletion or addition, but not gene
modification (Feist et al, 2009; Oberhardt et al, 2009; Orth et al, 2010; Price et al, 2003;
Raman & Chandra, 2009; Schellenberger et al, 2011). A mechanistic model based on
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kinetics could be used to predict how to genetically modify an existing enzyme to
increase production of a specific bioproduct.
A constraint based approach such as FBA results in a static model whereas a
kinetic based approach produces a dynamic model. As a static model, FBA also does not
account for the transcriptional network that regulates enzyme expression. Attempts have
been made to incorporate a regulatory network into FBA through the use of Boolean
logic operators (Orth et al, 2010; Price et al, 2003; Raman & Chandra, 2009). However, a
binary system based on Boolean logic operators fails to account for the entire dynamic
range of the regulatory system.
Metabolic profiling is a tool capable of providing the details needed for a
predictive mechanistic model. Metabolic profiling is a quantitative analysis of specific
metabolites over time. The general protocol for metabolic profiling is to take samples
from a culture and quench the metabolic activity. The two most common quenching
methods are freezing the samples with liquid nitrogen, or shocking with a cold-buffered
aqueous methanol mixture (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006;
Lu et al, 2008; Mashego et al, 2007; Ohashi et al, 2007).
Once samples have been prepared, specific metabolites can be analyzed through
combinations of liquid chromatography (LC), gas chromatography (GC), mass
spectrometry (MS), capillary electrophoresis (CE), and nuclear magnetic resonance
(NMR) (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006; Lu et al, 2008;
Mashego et al, 2007; Ohashi et al, 2007). Liquid chromatography coupled with mass
spectrometry (LC-MS) is a powerful tool because it is capable of analyzing many
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metabolites simultaneously using a small sample volume. One study successfully
analyzed as many as 69 metabolites simultaneously (Bajad et al, 2006).
LC-MS analysis can provide concentrations of metabolites at specific times in the
culture when compared to standard curves. These values can then be incorporated into the
predictive model so that the model more accurately represents the specific prokaryotic
strain under analysis. The predictive model can then be optimized for PHB production
and can identify the target genes for genetic engineering. After the prokaryotic strain has
been genetically engineered, another round of metabolic profiling can be conducted to
determine how the new strain performs compared to the optimized model.

Objectives

The objective of this project was to develop a mathematical model for PHB
synthesis in E. coli for the identification of key regulators and optimal conditions for
PHB synthesis. To achieve this objective, the model included pathways for glycolysis,
acetyl-CoA synthesis, TCA cycle, the glyoxylate pathway, and PHB synthesis. The
model incorporated enzymes, cofactors, and transcription factors for each reaction in the
pathways. The model was fitted to published models and to real-time data in order to
increase its accuracy. Metabolic profiling was employed to collect real-time data utilizing
LC-MS for metabolite identification and quantification. Sensitivity analysis was used on
the model to identify the key regulators and optimal conditions for the best PHB
production. The goal of this project was to provide direction for how to genetically
engineer E. coli to achieve higher production rates of PHB.
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PATHWAYS AND REACTIONS

Metabolic pathways are composed of biochemical reactions that allow organisms
to both degrade and construct compounds like PHB. Five metabolic pathways were
selected to be incorporated into this mathematical model based on criteria that include
energy, reducing power, and common substrates with the PHB synthesis pathway. The
five metabolic pathways were PHB synthesis, TCA cycle, glyoxylate pathway,
glycolysis, and acetyl-CoA synthesis.
Each pathway is a set of reactions that was modeled based on each reaction’s
kinetic mechanism. The kinetic mechanism and parameters are dependent upon the
enzyme that catalyzes each reaction. Studies on these enzymes have revealed many of
their kinetic mechanisms and parameters. This chapter explains the justifications behind
every equation and parameter used to model each reaction.

PHB Synthesis

The PHB synthesis pathway is composed of three biochemical reactions that
convert acetyl-CoA into PHB. This pathway contains two intermediates: acetoacetyl-CoA
and 3-hydroxybutyryl-CoA. The cofactors CoA and NADPH/NADP+ contribute to these
reactions. The enzymes β-ketothiolase (PhaA), acetoacetyl-CoA reductase (PhaB), and
poly-β-hydroxybutyrate polymerase (PhaC) each catalyze one of the three reactions
shown in Figure 1.
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Figure 1. The metabolic pathway for the synthesis of PHB.

Reaction 1:

↔
Enzyme: β-ketothiolase
The first step in PHB synthesis is catalyzed by the enzyme β-ketothiolase, also
known as acetyl-CoA acetyltransferase. The enzyme β-ketothiolase condenses two
acetyl-CoA molecules into one acetoacetyl-CoA in the forward reaction. The reversible
reaction is known as the thiolysis reaction. In many organisms, such as Ralstonia
eutropha (also previously known as Alcaligenes eutrophus and Cupriavidus necator),
there are two β-ketothiolases able to synthesize PHB. Enzyme A can utilize the substrates
acetoacetyl-CoA and 3-ketopentanoyl-CoA. Enzyme B can cleave a wider variety of
substrates that include: acetoacetyl-CoA, 3-ketoheptanoyl-CoA, 3-ketopentanoyl-CoA, 3ketohexanoyl-CoA, 3-ketooctanoyl-CoA, and 3-ketodecanoyl-CoA. Studies have shown
that enzyme B is the primary β-ketothiolase utilized in PHB synthesis (Madison &
Huisman, 1999; Slater et al, 1998).
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Forward Reaction:
The enzyme β-ketothiolase exhibits normal Michaelis-Menten kinetics in the
absence of CoA (Oeding & Schlegel, 1973; Senior & Dawes, 1973). In multiple
organisms, the enzyme displayed competitive-inhibition in the presence of CoA
(Haywood et al, 1988; Mothes et al, 1997; Oeding & Schlegel, 1973; Steinbüchel &
Schlegel, 1991). Based on the non-linear Lineweaver-Burk plots in the presence of CoA,
Oeding and Schlegel proposed a ping-pong mechanism with CoA as the binary term. Hill
kinetics were observed with coefficients of n = 1 in the absence of CoA and n = 2 in the
presence of CoA (Oeding & Schlegel, 1973).
Based on the findings described above, it was decided to use Equation (1) for the
condensation reaction. Equation (1) combines the kinetics of competitive-inhibition with
Hill cooperativity. Acetyl-CoA was used as the substrate, S, and CoA was used as the
inhibitor, I. The kinetic parameters utilized in simulations of this model are shown in
Table I. No kinetic data were available on E. coli for β-ketothiolase. Because the genes
for β-ketothiolase in E. coli come from R. eutropha, when available, it was preferable to
use kinetic data from R. eutropha (or A. eutrophus, C. necator) rather than from other
organisms. Because the enzyme B of β-ketothiolase is preferred over the enzyme A in
PHB synthesis (Madison & Huisman, 1999; Slater et al, 1998), Km values for enzyme B
were chosen over enzyme A in this model. No value in the literature was found for Vm in
R. eutropha. All values found for Vm are shown in Table I.
Reverse Reaction:
In the direction of thiolysis, β-ketothiolase does not obey Michaelis-Menten
kinetics. Studies indicate that there is a positive cooperativity between acetoacetyl-CoA
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and CoA (Haywood et al, 1988; Steinbüchel & Schlegel, 1991). Lineweaver-Burk plots
yield a family of parallel lines at varied concentrations of acetoacetyl-CoA or CoA.
Parallel lines indicate that this reaction follows a ping-pong bi-bi mechanism (Molina et
al, 1994; Oeding & Schlegel, 1973).
For this model, it was decided to use Equation (2), the ping-pong bi-bi
mechanism, for the thiolysis reaction. Acetoacetyl-CoA was used as substrate A, and
CoA was used as substrate B. Kinetic parameters utilized in simulations of this model are
shown in Table I. No kinetic data were available on E. coli for β-ketothiolase.
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Table I. Kinetic parameters utilized for Reaction 1 in the model.
Parameter Value Units
Organism
Reference
Km
230b µM
A. eutrophus
Steinbüchel & Schlegel, 1991
390 µM
C. necator
Oeding & Schlegel, 1973
a
1100
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Vm
0.0078 µM/s A. beijerinckii
Senior & Dawes, 1973
0.0088 µM/s
M. sedula
Berg et al, 2007
Fwd
0.0177 µM/s
M. sedula
Berg et al, 2007
Rxn
0.115 µM/s R. sphaeroides
Alber et al, 2006
0.32 µM/s M. rhodesianum
Mothes et al, 1997
1.92 µM/s
C. kluyveri
Sliwkowski & Hartmanis, 1984
Ki
16 µM
A. eutrophus
Steinbüchel & Schlegel, 1991
n
2
C. necator
Oeding & Schlegel, 1973
a
KA
44
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
b
394
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Rev
a
KB
16
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Rxn
b
93
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Vm
1.24 µM/s M. rhodesianum
Mothes et al, 1997
a. Enzyme A of β-ketothiolase
b. Enzyme B of β-ketothiolase

Reaction 2:

↔

Enzyme: Acetoacetyl-CoA reductase
Acetoacetyl-CoA reductase catalyzes the second step in PHB synthesis by
converting acetoacetyl-CoA into 3-hydroxybutyryl-CoA. It has been classified as a
NADPH-dependent reductase. The availability of reducing power is one of the main
driving forces for PHB synthesis. Thiolysis is the thermodynamically favored direction;
however, under favorable PHB accumulating conditions, acetoacetyl-CoA reductase can
pull the reaction in the condensation direction (Madison & Huisman, 1999).
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Forward Reaction:
The kinetics of acetoacetyl-CoA reductase vary by organism. The enzyme has
been shown to have cooperativity factors in M. extorquens for acetoacetyl-CoA and
NADPH (Belova et al, 2006). However, it has been shown that there are no cooperativity
factors in M. rhodesianum (Mothes & Babel, 1994). Kinetic behavior indicates inhibition
with the substrate acetoacetyl-CoA at high concentrations in multiple organisms (Belova
et al, 2006; Mothes & Babel, 1994; Ploux et al, 1988). Normal Michaelis-Menten
kinetics have been observed in A. beijerinckii (Ritchie et al, 1971). Also, a sequential
kinetic mechanism has been observed in Z. ramigera (Ploux et al, 1988).
The literature contained Km values for acetoacetyl-CoA and NADPH/NADH
(Steinbüchel & Schlegel, 1991) in A. eutrophus, but no mechanism was proposed. Due to
the dependence on NADPH/NADH and the sequential kinetic mechanism observed in Z.
ramigera, it was decided to use an ordered bi-bi mechanism, Equation (3), to model this
reaction. Substrate A was acetoacetyl-CoA, and substrate B was NADPH/NADH. The
NADPH dependent enzyme is the one used in PHB synthesis (Madison & Huisman,
1999); therefore, kinetic parameters for the NADPH dependent enzyme shown in Table II
were used in the model.
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Reverse Reaction:
The literature contained no proposed kinetic mechanism for the thiolysis reaction
catalyzed by acetoacetyl-CoA reductase. However, Km values for β-hydroxybutyryl-CoA
and NADP+/NAD+ were found in A. eutrophus (Steinbüchel & Schlegel, 1991). It was
decided to model this reaction with the same mechanism utilized in the condensation
reaction. An ordered bi-bi mechanism, Equation (3), was employed with substrate A as βhydroxybutyryl-CoA and substrate B as NADP+/NAD+.
Although both NADPH and NADH dependent acetoacetyl-CoA reductase exist in
A. eutrophus, only the NADPH dependent enzyme is used in PHB synthesis (Madison &
Huisman, 1999). Therefore, kinetic parameters for the NADPH dependent enzyme were
used in the model as shown in Table II. The parameter Vm was not found for the thiolysis
reaction. The same value used in the condensation reaction was used in the thiolysis
reaction model.

Table II. Kinetic parameters utilized for Reaction 2 in the model.
Parameter Value Units
Organism
Reference
a
KA
5
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
22b µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Fwd
a
KB
19
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Rxn
b
13
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Vm
0.023 µM/s R. sphaeroides
Alber et al, 2006
a
KA
33
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
b
26
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Rev
a
KB
31
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Rxn
b
16
µM
A. eutrophus
Steinbüchel & Schlegel, 1991
Vm
0.023 µM/s R. sphaeroides
Alber et al, 2006
a.
b.

NADPH dependent
NADH dependent
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Reaction 3:

( )

→

( )

Enzyme: Poly-β-hydroxybutyrate polymerase (PHB synthase)
The enzyme poly-β-hydroxybutyrate polymerase, also known as PHB synthase,
catalyzes the third step in the PHB synthesis pathway. This enzyme exists in both soluble
and granule-associated forms (Haywood et al, 1989; Madison & Huisman, 1999). In
carbon-limited environments, most PHB synthase is soluble. In nitrogen-limited
environments, the majority of PHB synthase is granule-associated (Haywood et al, 1989).
PHB synthase can polymerize 3-hydroxybutyrate units to form poly-3-hydroxybutyrate
(PHB) and 3-hydroxyvalerate units to form polyhydroxyalkanoate (PHA) (Haywood et
al, 1989).

Forward Reaction:
Poly-β-hydroxybutyrate polymerase demonstrated normal Michaelis-Menten
kinetics in A. eutrophus (Haywood et al, 1989). Equation (4) was used to model the
forward reaction using kinetic parameters from Table III. The molecular weight of PHB
assumed for this model was 160,000 Daltons because of its association with the kinetic
parameters in Table III (Haywood et al, 1989). Using the molecular weight of 160 kDa
results in a PHB polymer composed of 1,860 units of 3-hydroxybutyrate. The
stoichiometric coefficient n in Reaction 3 was set as 1,860 in the model. Kinetic
parameters for the granule-associated PHB synthase were used in the model due to the
unstable nature of the soluble PHB synthase (Haywood et al, 1989).
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Reverse Reaction:
The reverse reaction was ignored in this model because E. coli do not naturally
code for PHB depolymerase (Saito et al, 1989). The PHB depolymerase gene will not be
cloned into E. coli because it is desired to accumulate, not degrade, PHB.
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Table III. Kinetic parameters utilized for Reaction 3 in the model.
Parameter
Value
Units
Organism
a,c
Km
680
µM
A. eutrophus
a,d
720
µM
A. eutrophus
Fwd
b,c
1630
µM
A. eutrophus
Rxn
Vm
0.0047
µM/s
A. eutrophus
a.
b.
c.
d.

(4)

Reference
Haywood et al, 1989
Haywood et al, 1989
Haywood et al, 1989
Haywood et al, 1989

(R)-3-hydroxybutyryl-CoA as substrate
(R)-3-hydroxyvaleryl-CoA as substrate
Granule associated synthase
Soluble synthase

TCA Cycle

The tricarboxylic acid (TCA) cycle is composed of nine reactions that utilize
acetyl-CoA to generate energy and reducing power. Nine enzymes catalyze the reactions
in the TCA cycle as shown in Figure 2. The TCA cycle uses the cofactors CoA,
ADP/ATP, NAD+/NADH, and NADP+/NADPH. The TCA cycle takes a portion of
acetyl-CoA away from PHB synthesis. Cells need energy, reducing power, and acetylCoA to produce PHB, so the TCA cycle is an important pathway to include in the model.
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Figure 2. The metabolic pathway for the TCA cycle.

Reaction 4:

↔

Enzyme: Citrate synthase
Citrate synthase catalyzes the Claisen condensation reaction that forms citrate
from oxaloacetate and acetyl-CoA. Citrate synthase is controlled through activators and
inhibitors. Acetyl-CoA acts as an allosteric activator and K+ acts as a non-allosteric
inhibitor. Allosteric inhibitors include NADH, NAD+, and oxaloacetate. ATP and 2oxoglutarate act as competitive inhibitors. Other inhibitors include citrate, isocitrate, and
cis-aconitate (Anderson & Duckworth, 1988; Duckworth et al, 1987; Man et al, 1995;
Senior & Dawes, 1973; Walsh & Koshland, 1985).
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Forward Reaction:
Studies have demonstrated sequential ordered bi-bi kinetics, with oxaloacetate
binding first, in E. coli for this reaction (Anderson & Duckworth, 1988). Studies have
also demonstrated that citrate synthase exhibits competitive inhibition with 2oxoglutarate (Anderson & Duckworth, 1988; Pereira et al, 1994).
An ordered bi-bi kinetic mechanism, Equation (3), was used to model the forward
reaction catalyzed by citrate synthase. Substrate A was oxaloacetate and substrate B was
acetyl-CoA. Kinetic parameters utilized in the model are shown in Table IV. The values
chosen were from various strains of E. coli.

Table IV. Kinetic parameters utilized for Reaction 4 in the model.
Parameter
Value Units
Organism
Reference
KA
460 µM E. coli H229Q Anderson & Duckworth, 1988
17 µM E. coli H226Q Anderson & Duckworth, 1988
26 µM
E. coli wild
Anderson & Duckworth, 1988
KB
190 µM E. coli H229Q Anderson & Duckworth, 1988
Fwd
260 µM E. coli H226Q Anderson & Duckworth, 1988
Rxn
120 µM
E. coli wild
Anderson & Duckworth, 1988
kcat
9.3
s
E. coli H229Q Anderson & Duckworth, 1988
98
s
E. coli H226Q Anderson & Duckworth, 1988
81
s
E. coli wild
Anderson & Duckworth, 1988
KA
159 µM
Rat kidney
Matsuoka & Srere, 1973
420 µM
Human heart
Mukherjee et al, 1980
Rev
KB
32 µM
Rat kidney
Matsuoka & Srere, 1973
Rxn
70 µM
Human heart
Mukherjee et al, 1980
Vm
1.67E-4 µM/s
Rat kidney
Matsuoka & Srere, 1973

Reverse Reaction:
No kinetic data were found for the reverse of Reaction 4 in E. coli. Studies of the
citrate synthase in rat kidneys and the human heart provided kinetic parameters for the
reverse reaction catalyzed by citrate synthase (Matsuoka & Srere, 1973; Mukherjee et al,
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1980). Studies suggest that a random bi-bi mechanism is employed by this reaction
(Matsuoka & Srere, 1973). Equation (5) represents a random bi-bi kinetic mechanism.
Therefore, Equation (5) and the kinetic parameters in Table IV were used to model the
reverse reaction in SimBiology with substrate A as citrate and substrate B as CoA.



k cat * [E]
VMAX

K A K B K A K B
K A K B K A K B
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1
[A][B]
[A]
[B]
[A][B]
[A]
[B]
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KA
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(5)

kcat*[E] = [µM/s]
Dissociation constant for substrate A = [µM]
Dissociation constant for substrate B = [µM]
Maximum number of rxns catalyzed per second = [s-]
Concentration of substrate A = [µM]
Concentration of substrate B = [µM]
Concentration of enzyme = [µM]
Binding interaction factor
If α = 1, substrate binding is independent
If α > 1, binding of substrate decreases affinity of other
If α < 1, binding of substrate increases affinity of other

Reaction 5:

↔

Enzyme: Citrate hydro-lyase
Citrate hydro-lyase is an aconitase that catalyzes the reversible isomerization of
citrate. E. coli has two major aconitases, AcnA and AcnB. AcnA is the aerobic-stationary
phase enzyme, and AcnB is the major TCA cycle enzyme during exponential growth.
AcnA is more stable than AcnB, and has a higher affinity for citrate. AcnB is the main
catabolic enzyme because its sensitivity to oxidative or pH stress allows it to regulate the
TCA cycle (Jordan et al, 1999).
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Forward Reaction:
Studies indicate that this reaction exhibits normal Michaelis-Menten kinetics.
Equation (4) was used to model the forward reaction. Kinetic parameters were found for
both AcnA and AcnB as seen in Table V. It was decided to use AcnB values for this
model because AcnB is the major TCA cycle enzyme (Jordan et al, 1999).

Reverse Reaction:
Studies indicate that this reaction exhibits Michaelis-Menten kinetics with a Hill
cooperativity factor of 2.1 (Tsuchiya et al, 2009). Equation (6) represents Hill kinetics
and was used to model the reverse reaction with the kinetic parameters found in Table V.

VMAX [S] n k cat * [E] * [S] n


K M  [S] n
K M  [S] n
VMAX
KM
kcat
[S]
[E]
n

=
=
=
=
=
=

kcat*[E] = [µM/s]
Substrate concentration resulting in 0.5VMAX = [µM]
Maximum number of rxns catalyzed per second = [s-]
Concentration of substrate = [µM]
Concentration of enzyme = [µM]
Hill cooperativity coefficient

Table V. Kinetic parameters utilized for Reaction 5 in the model.
Parameter
Value Units
Organism
a
Km
1160
µM
E. coli K-12 MG1655
b
11000
µM
E. coli K-12 MG1655
Fwd
a
Vm
0.102
µM/s E. coli K-12 MG1655
Rxn
0.397b µM/s E. coli K-12 MG1655
Km
58a
µM
E. coli K-12 MG1655
b
16
µM
E. coli K-12 MG1655
Rev
a
Vm
0.242
µM/s E. coli K-12 MG1655
Rxn
b
0.652
µM/s E. coli K-12 MG1655
n
2.1
E. coli K-12 MG1655
a.
b.

acnA
acnB

(6)

Reference
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Tsuchiya et al, 2009
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Reaction 6:

↔

Enzyme: Isocitrate hydro-lyase
Isocitrate hydro-lyase is an aconitase that catalyzes the reversible isomerization of
aconitate. As mentioned previously, E. coli has two major aconitases, AcnA and AcnB.

Forward Reaction:
Studies show that this reaction exhibits normal Michaelis-Menten kinetics with
negative cooperativity (Jordan et al, 1999; Tsuchiya et al, 2009). Equation (6) was used
to model the forward reaction. Kinetic parameters were found for both AcnA and AcnB
as seen in Table VI. AcnB values were used for this model because AcnB is the major
TCA cycle enzyme (Jordan et al, 1999).

Table VI. Kinetic parameters utilized for Reaction 6 in the model.
Parameter
Value Units
Organism
Km
58a µM E. coli K-12 MG1655
16b µM E. coli K-12 MG1655
Fwd
Vm
0.242a µM/s E. coli K-12 MG1655
Rxn
0.652b µM/s E. coli K-12 MG1655
n
0.727
E. coli K-12 MG1655
a
Km
14
µM E. coli K-12 MG1655
b
51
µM E. coli K-12 MG1655
Rev
a
Rxn
Vm
0.0595 µM/s E. coli K-12 MG1655
0.0987b µM/s E. coli K-12 MG1655
a.
b.

acnA
acnB

Reference
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Tsuchiya et al, 2009
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
Jordan et al, 1999
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Reverse Reaction:
Studies indicate that this reaction exhibits Michaelis-Menten kinetics (Jordan et
al, 1999). Equation (4) was used to model the reverse reaction. Kinetic parameters were
found for both AcnA and AcnB as seen in Table VI. AcnB values were used for this
model because AcnB is the major TCA cycle enzyme (Jordan et al, 1999).

Reaction 7:

→

Enzyme: Isocitrate dehydrogenase
Isocitrate dehydrogenase catalyzes the irreversible oxidative decarboxylation of
isocitrate to 2-oxoglutarate. The enzyme is regulated by phosphorylation and
dephosphorylation. Isocitrate is important because it allows E. coli to switch between the
TCA cycle and the glyoxylate bypass pathway.

Forward Reaction:
Studies indicate that the reaction catalyzed by isocitrate dehydrogenase displays
normal Michaelis-Menten kinetics (Lee et al, 1995). Therefore, Equation (4) was used to
model the reaction utilizing the kinetic parameters from Table VII.

Table VII. Kinetic parameters utilized for Reaction 7 in the model.
Parameter
Value
Units
Organism
Km
11.4
µM
E. coli
6030
µM
E. coli K230M
9.6
µM
E. coli Y160F
Fwd
kcat
76.2
s
E. coli
Rxn
0.85
s
E. coli K230M
0.311
s
E. coli Y160F

Reference
Lee et al, 1995
Lee et al, 1995
Lee et al, 1995
Lee et al, 1995
Lee et al, 1995
Lee et al, 1995
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Reaction 8:

→

Enzyme: 2-oxoglutarate dehydrogenase complex
The 2-oxoglutarate dehydrogenase complex catalyzes the irreversible oxidative
decarboxylation of 2-oxoglutarate to succinyl-CoA. The complex contains three
components: 2-oxoglutarate decarboxylase (E1), lipoamide acyltransferase (E2), and
lipoamide dehydrogenase (E3).

Forward Reaction:
The net forward reaction demonstrated normal Michaelis-Menten kinetics
(McCormack & Denton, 1981). The kinetic parameters in Table VIII were used with
Equation (4) to model the forward reaction.

Table VIII. Kinetic parameters utilized for Reaction 8 in the model.
Parameter
Value Units Organism
Reference
Km
9.2
µM
E. coli
McCormack & Denton, 1981
Fwd
10.5
µM
E. coli
McCormack & Denton, 1981
Rxn
Vm
0.00363 µM /s
E. coli
McCormack & Denton, 1981

Reaction 9:

↔

Enzyme: Succinyl-CoA synthetase
Succinyl-CoA synthetase catalyzes substrate level phosphorylation in the TCA
cycle by converting succinyl-CoA and ADP into succinate and ATP. In E. coli, the
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enzyme exists as a tetramer and favors adenine over guanine nucleotides. In eukaryotes,
guanine nucleotides are preferred (Birney et al, 1996). It is a multiple step reaction that
uses a covalent enzyme-substrate intermediate. The phosphate group is transferred to the
enzyme resulting in a phosphoenzyme that is then used to convert ADP into ATP.

Forward Reaction:
In the forward reaction, enzyme bound succinyl-phosphate is formed as an
intermediate. The phosphate group is transferred to a histidine residue and succinate is
released as a product. The phosphoenzyme then generates the second product, ATP.
The kinetic mechanism behind this reaction is not well understood. The reaction
is similar to many reactions classified as ping-pong, but some studies support a sequential
mechanism and the formation of a quaternary structure. Studies indicate that ADP is an
allosteric regulator of the enzyme during the forward reaction (Um & Klein, 1993). The
reaction displays an unusual catalytic property called substrate synergism. The presence
of a substrate for one reaction stimulates another reaction. The exact mechanism for
substrate synergism has yet to be defined in terms of an equation (Birney et al, 1996; Um
& Klein, 1993).
Due to the lack of a kinetic mechanism and parameters, this reaction was modeled
by using simple mass-action kinetics. It is hoped that future studies can provide a more
accurate kinetic mechanism for this specific reaction.

Reverse Reaction:
The reverse reaction also has unusual catalytic properties, but some studies
supported a sequential mechanism and were able to measure some kinetic parameters
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(Joyce et al, 1999; Luo & Nishimura, 1991; Moffet & Bridger, 1970). An ordered bi-bi
mechanism, Equation (3), was used to model the reverse reaction with substrate A as
succinate and substrate B as CoA. The parameters shown in Table IX were used for
Reaction 9 of the model.

Table IX. Kinetic parameters utilized for Reaction 9 in the model.
Parameter
Value Units Organism
Reference
Fwd
k
1
sNA
NA
Rxn
KA
590 µM
E. coli
Luo & Nishimura, 1991
620 µM
E. coli
Luo & Nishimura, 1991
250 µM
E. coli
Joyce et al, 1999
Rev
KB
7.6 µM
E. coli
Luo & Nishimura, 1991
Rxn
18 µM
E. coli
Luo & Nishimura, 1991
4.0 µM
E. coli
Joyce et al, 1999
kcat
24.52
s
E. coli
Joyce et al, 1999

Reaction 10:

↔

Enzyme: Succinate dehydrogenase
Succinate dehydrogenase catalyzes the oxidation of succinate to fumarate under
aerobic conditions. It can also catalyze the reverse reaction, the reduction of fumarate to
succinate. Succinate dehydrogenase requires flavins, ubiquinone, or menaquinol as
electron donors and acceptors.

Forward Reaction:
The oxidation of succinate to fumarate has demonstrated normal MichaelisMenten kinetics in studies of E. coli (Cecchini et al, 2002; Maklashina et al, 2006). One
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study indicated that succinate dehydrogenase was inhibited by oxaloacetate and
malonate, but no mechanism was identified (Maklashina et al, 2006). This model utilized
a noncompetitive inhibition mechanism, Equation (7), with oxaloacetate as the inhibitor.
Kinetic parameters utilized in this model are shown in Table X.
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(7)

kcat*[E] = [µM/s]
Substrate concentration resulting in 0.5VMAX = [µM]
Inhibitor concentration in 0.5VMAX = [µM]
Maximum number of rxns catalyzed per second = [s-]
Concentration of substrate = [µM]
Concentration of enzyme = [µM]
Concentration of inhibitor = [µM]

Reverse Reaction:
The reduction of fumarate to succinate has displayed normal Michaelis-Menten
kinetics in E. coli (Cecchini et al, 2002; Maklashina et al, 2006). This model utilized
Equation (4) to simulate this reaction. Kinetic parameters utilized in this model are shown
in Table X.

Table X. Kinetic parameters utilized for Reaction 10 in the model.
Parameter
Value
Units
Organism
Reference
Km
110
µM
E. coli
Maklashina et al, 2006
2
µM
E. coli
Cecchini et al, 2002
Fwd
Ki
0.07
µM
E. coli
Maklashina et al, 2006
Rxn
kcat
110
s
E. coli
Maklashina et al, 2006
85
s
E. coli
Cecchini et al, 2002
Km
100
µM
E. coli
Maklashina et al, 2006
5
µM
E. coli
Cecchini et al, 2002
Rev
Rxn
kcat
2
s
E. coli
Maklashina et al, 2006
1.7
s
E. coli
Cecchini et al, 2002
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Reaction 11:

↔

Enzyme: Fumarase
Fumarase catalyzes the reaction between fumarate and malate in the TCA cycle.
There are three fumarase isozymes in E. coli. Fumarase A has the most activity under
microaerophilic condition and is inactivated under aerobic conditions. Fumarase B has
some activity in microaerophilic and aerobic conditions. Fumarase B also has a higher
affinity for malate than fumarate. Fumarase C is highly active under aerobic conditions
(Woods et al, 1988).

Forward and Reverse Reaction:
No kinetic mechanism was identified for Reaction 11. Normal Michaelis-Menten
kinetics were assumed for the forward and reverse reactions. Equation (4) and the kinetic
parameters in Table XI were utilized in the model of the forward and reverse reactions.

Table XI. Kinetic parameters utilized for Reaction 11 in the model.
Parameter
Value Units Organism
Reference
Km
100
µM
E. coli
Rose & Weaver, 2004
Fwd Rxn
kcat
60
s
E. coli
Rose & Weaver, 2004
Km
300
µM
E. coli
Rose & Weaver, 2004
Rev Rxn
kcat
129
s
E. coli
Rose & Weaver, 2004

Reaction 12:

↔
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Enzyme: Malate dehydrogenase
Malate dehydrogenase catalyzes the reversible oxidation of malate to
oxaloacetate. The enzyme uses NAD+ as an electron acceptor. The activity of malate
dehydrogenase is lower under anaerobic conditions.

Forward Reaction:
Studies indicate that this reaction follows an ordered bi-bi mechanism (Heyde &
Ainsworth, 1968; Muslin et al, 1995). Equation (3) was used to model the forward
reaction with substrate A as malate and substrate B as NAD+. The kinetic parameters
found in Table XII were utilized for the forward reaction in the model.

Reverse Reaction:
It was assumed that the reverse reaction would also follow an ordered bi-bi
mechanism, so Equation (3) was employed to model the reaction with substrate A as
oxaloacetate and substrate B as NADH. The kinetic parameters found in Table XII were
used to model this reaction.

Table XII. Kinetic parameters utilized for Reaction 12 in the model.
Parameter
Value
Units
Organism
Reference
KA
2600
µM
E. coli
Muslin et al, 1995
Fwd
KB
260
µM
E. coli
Muslin et al, 1995
Rxn
kcat
21
s
E. coli
Muslin et al, 1995
KA
49
µM
E. coli
Muslin et al, 1995
Rev
KB
61
µM
E. coli
Muslin et al, 1995
Rxn
kcat
900
s
E. coli
Muslin et al, 1995
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Glyoxylate Pathway

The glyoxylate pathway is a shunt in the TCA cycle. It is composed of two
reactions catalyzed by the enzymes isocitrate lyase and malate synthase shown in Figure
3. Using additional acetyl-CoA, this pathway can convert isocitrate into malate and
succinate bypassing the conversion into 2-oxoglutarate and succinyl-CoA. This shunt
generates intermediates to be used elsewhere in the cell, but fails to generate the energy
and reducing power that is generated when isocitrate continues through the TCA cycle.
The glyoxylate shunt is included in this model to more accurately represent the energy
and reducing power generated in the TCA cycle.

Figure 3. The metabolic pathway for the glyoxylate shunt in the TCA cycle.
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Reaction 13:

↔

Enzyme: Isocitrate lyase
Isocitrate lyase catalyzes the cleavage of isocitrate into glyoxylate and succinate.
This enzyme diverts isocitrate from the TCA cycle into the glyoxylate shunt.

Forward Reaction:
Isocitrate lyase cleaves isocitrate into glyoxylate and succinate in the forward
direction. The pH in E. coli cells is around 7.3 to 7.6 (Mackintosh & Nimmo, 1988);
therefore, the parameters measured at pH = 7.3 were utilized in the model.
Phosphoenolpyruvate acts as a non-competitive inhibitor, but the Ki value suggests it is
not significant in vivo. The species 3-phosphoglycerate is a competitive inhibitor of
isocitrate lyase and is more significant due to its higher concentrations in the cell
(Mackintosh & Nimmo, 1988). Equation (8) was used to model the competitive inhibition
mechanism with 3-phosphoglycerate utilizing the parameters found in Table XIII.
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kcat*[E] = [µM/s]
Substrate concentration resulting in 0.5VMAX = [µM]
Inhibitor concentration in 0.5VMAX = [µM]
Maximum number of rxns catalyzed per second = [s-]
Concentration of substrate = [µM]
Concentration of enzyme = [µM]
Concentration of inhibitor = [µM]

(8)
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Table XIII. Kinetic parameters utilized for Reaction 13 in the model.
Parameter Value Units
Organism
Reference
Km
63a µM
E. coli ML308
Mackintosh & Nimmo, 1988
32b µM
E. coli ML308
Mackintosh & Nimmo, 1988
a
Ki,PEP
910
µM
E. coli ML308
Mackintosh & Nimmo, 1988
b
100
µM
E. coli ML308
Mackintosh & Nimmo, 1988
Fwd
a
Ki,3PG
800
µM
E. coli ML308
Mackintosh & Nimmo, 1988
Rxn
b
360
µM
E. coli ML308
Mackintosh & Nimmo, 1988
kcat
28.5
s
E. coli ML308
Robertson & Nimmo, 1995
19.5
s
C. acremonium
Perdiguero et al, 1995
KA
590 µM
E. coli ML308
Mackintosh & Nimmo, 1988
Rev
KB
130 µM
E. coli ML308
Mackintosh & Nimmo, 1988
Rxn
kcat
15.7
s
C. acremonium
Perdiguero et al, 1995
a. pH = 7.3
b. pH = 6.8

Reverse Reaction:
Isocitrate lyase condenses glyoxylate and succinate into isocitrate in the reverse
reaction. This reaction occurs by a sequential random-order equilibrium mechanism
where the substrate binding of glyoxylate and succinate are independent (Mackintosh &
Nimmo, 1988). Equation (5) and the parameters in Table XIII were used to model the
reaction with substrate A as succinate and substrate B as glyoxylate.

Reaction 14:

→

Enzyme: Malate synthase
Malate synthase exists as two isozymes in E. coli. Malate synthase A is the
enzyme utilized in the glyoxylate shunt in the TCA cycle. Malate synthase A catalyzes
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the irreversible reaction of glyoxylate and acetyl-CoA into malate. Malate synthase B
catalyzes the synthesis of glyoxylate from glycolate (Molina et al, 1994).

Forward Reaction:
Malate synthase catalyzes the Claisen condensation of glyoxylate and acetyl-CoA
into a malyl-CoA intermediate. The malyl-CoA intermediate is then cleaved into the two
products, malate and CoA. Pyruvate is a competitive inhibitor to malate synthase
(Anstrom et al, 2003). Studies indicate that this reaction proceeds through a random
sequential mechanism with independent substrate binding. Equation (5) and the kinetic
parameters shown Table XIV were used to model the reaction with substrate A as
glyoxylate and substrate B as acetyl-CoA.

Table XIV. Kinetic parameters utilized for Reaction 14 in the model.
Parameter Value Units
Organism
Reference
KA
21
µM
E. coli
Anstrom et al, 2003
100
µM
S. cerevisiae
Durchschlag et al, 1981
KB
9.0
µM
E. coli
Anstrom et al, 2003
Fwd
83
µM
S. cerevisiae
Durchschlag et al, 1981
Rxn
Ki
1000
µM
E. coli
Anstrom et al, 2003
α
1.0
S. cerevisiae
Durchschlag et al, 1981
kcat
48.1
s
E. coli
Anstrom et al, 2003
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Glycolysis/Gluconeogenesis

Glycolysis is the metabolic pathway that breaks down glucose into pyruvate while
generating a small amount of energy and reducing power. Glycolysis is composed of ten
reactions seen in Figure 4. The enzymes that catalyze these ten reactions are glucokinase,
phosphoglucose isomerase, 6-phosphofructokinase, fructose-bisphosphate aldolase, triose
phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate
kinase, phosphoglycerate mutase, enolase, and pyruvate kinase. Cofactors that participate
in glycolysis are ADP/ATP, NADH/NAD+, and Pi. Glycolysis was included in this model
because glucose is a common substrate used to grow cells and produce PHB.
Gluconeogenesis is a metabolic pathway that can convert pyruvate back into
glucose. It includes many of the same enzymes as glycolysis. Gluconeogenesis uses five
additional enzymes: glucose-1-phosphatase, phosphoglucomutase, fructose-1,6bisphosphatase, phosphoenolpyruvate carboxykinase, and phosphoenolpyruvate
synthetase. Gluconeogenesis includes 12 reactions as shown in Figure 4.
Gluconeogenesis was included in this model to account for the conversion of pyruvate
into glucose. Gluconeogenesis can occur when the concentrations of acetyl-CoA and
citrate are high and the concentration of glucose is low.

Reaction 15:
Forward Reaction:

→
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igure 4. The metabolic pathway for glycolysis and gluconeogenesis.
The forward reaction is catalyzed by the enzyme glucokinase. Glucokinase
phosphorylates glucose into the product glucose-6-phosphate. The reaction requires ATP
to proceed. The kinetic mechanism for glucokinase has been studied in several organisms
such as Z. mobilis and P. shermanii. It is hypothesized that the mechanism will be the
same in E. coli because it is consistent with the crystal structure of the E. coli
glucokinase. Studies indicate that the mechanism is a preferred order of substrate addition
and product release. Glucose is added first followed by ATP (Lunin et al, 2004). An
ordered bi-bi mechanism, Equation (3), was used to model the forward reaction with the
kinetics parameters found in Table XV.

Reverse Reaction:
The conversion of glucose-6-phosphate back into glucose is a two step process
that involves two enzymes: phosphoglucomutase and glucose-1-phosphatase.

Step 1:

↔

Step one is a reversible reaction catalyzed by phosphoglucomutase where
glucose-6-phosphate is converted into glucose-1-phosphate via the intermediate glucose1,6-diphosphate. No kinetic data were found for E. coli in the direction of glucose-6phosphate to glucose-1-phosphate, but there was kinetic data from phosphoglucomutase
in rat heart cells. Normal Michaelis-Menten kinetics, Equation (4), were assumed and
kinetic parameters found in Table XV were utilized in the model.
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A thermophilic phosphoglucomutase that was similar to the E. coli enzyme
demonstrated a ping-pong catalytic mechanism in the direction of glucose-1-phosphate to
glucose-6-phosphate (Yoshizaki et al, 1971). Other studies have also suggested a pingpong mechanism (Ray & Roscelli, 1964). It was decided to use normal Michaelis-Menten
kinetics for the reverse direction of Step 1 to simplify the model. Equation (4) was
utilized along with the kinetic parameters found in Table XV.

Step 2:

→

Step 2 is an irreversible reaction where glucose-1-phosphate is converted into
glucose by the enzyme glucose-1-phophatase. Normal Michaelis-Menten kinetics,
Equation (4), were used to model the reaction with the parameters found in Table XV.

Table XV. Kinetic parameters utilized for Reaction 15 in the model.
Parameter Value
Units
Organism
Reference
KA
780
µM
E. coli
Meyer et al, 1997
Fwd
KB
3760
µM
E. coli
Meyer et al, 1997
Rxn
Vm
2.643
µM/s
E. coli
Meyer et al, 1997
KM
670
µM
Rat heart
Kashiwaya et al, 1994
Rev Rxn
Vm
1.12
µM/s
Rat heart
Kashiwaya et al, 1994
Step 1 Fwd
Km
60
µM
E. coli
Josh & Handler, 1964
Rev Rxn
6700
µM
E. coli
Dworniczak et al, 2008
Step 1 Rev
Vm
0.001 µM /s
E. coli
Dworniczak et al, 2008
Km
240
µM
E. coli
Kuznetsova et al, 2006
Rev Rxn
kcat
1.4
s
E. coli
Kuznetsova et al, 2006
Step 2

Reaction 16:

↔
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Enzyme: Phosphoglucose isomerase
Reaction 16 is a reversible reaction catalyzed by the enzyme phosphoglucose
isomerase. The enzyme converts glucose-6-phosphate into fructose-6-phosphate or vice
versa.

Forward and Reverse Reaction:
A study in E. coli indicated that the kinetic mechanism utilized in this reaction
was a uni-uni reversible that utilized the Haldane relationship (Ishii et al, 2007). Equation
(9) and the kinetic parameters shown in Table XVI were used to model this reaction.
Glucose-6-phosphate was used as substrate A, and fructose-6-phosphate was used as
substrate B. The reverse reaction uses the same kinetics as the forward reaction (Ishii et
al, 2007); therefore, it was modeled using the same equation and parameters.
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(9)

kcat*[E] = [µM/s]
Dissociation constant for substrate A = [µM]
Dissociation constant for substrate B = [µM]
Maximum number of rxns catalyzed per second = [s-]
Equilibrium constant [unitless]
Concentration of substrate A = [µM]
Concentration of substrate B = [µM]
Concentration of enzyme = [µM]

Table XVI. Kinetic parameters utilized for Reaction 16 in the model.
Parameter
Value
Units
Organism
KA
3000
µM
E. coli K-12
KB
160
µM
E. coli K-12
Fwd
Keq
0.3
E. coli K-12
Rxn
Vm
25.18
µM/s
E. coli K-12

Reference
Ishii et al, 2007
Ishii et al, 2007
Ishii et al, 2007
Ishii et al, 2007
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Reaction 17:
Forward Reaction:

→

Enzyme: 6-phosphofructokinase
The ATP dependent 6-phosphofructokinase catalyzes the phosphorylation of
fructose-6-phosphate into fructose-1,6-bisphosphate. An ordered bi-bi reaction
mechanism has been proposed for this reaction in E. coli with fructose-6-phosphate as
substrate A and ATP as substrate B (Campos et al, 1984). Equation (3) and the kinetic
parameters shown in Table XVII were utilized in the model of the forward direction of
Reaction 17.

Reverse Reaction:

→

Enzyme: Fructose-1,6-bisphosphatase
Fructose-1,6-bisphosphatase catalyzes the dephosphorylation of fructose-1,6bisphosphate to fructose-6-phosphate. There are four major genes that encode for
fructose-1,6-bisphosphatase in E. coli: fbp, yphA, yggF, glpX. Fbp is the main fructose1,6-bisphosphatase in the cell. YggF and GlpX are type II fructose-1,6-bisphosphatases.
Hill kinetics have been shown for this reaction in E. coli with a cooperativity
factor of 2.0 (Brown et al, 2009). Equation (6) and the kinetic parameters shown in Table
XVII were used to model the reverse direction of Reaction 17. Values for all four
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fructose-1,6-bisphosphatases are shown in Table XVII but only values for Fbp were used
in the model.

Table XVII. Kinetic parameters utilized for Reaction 17 in the model.
Parameter
Value Units
Organism
Reference
KA
107
µM
E. coli
Wang & Kemp, 1999
32
µM
E. coli
Campos et al, 1984
Fwd
KB
210
µM
E. coli
Wang & Kemp, 1999
Rxn
20
µM
E. coli
Campos et al, 1984
kcat
82
sE. coli
Wang & Kemp, 1999
Km
20a
µM
E. coli
Brown et al, 2009
b
2400
µM
E. coli
Brown et al, 2009
c
70
µM
E. coli
Brown et al, 2009
100d
µM
E. coli
Brown et al, 2009
a
Vm
0.403
µM /s
E. coli
Brown et al, 2009
b
0.16
µM /s
E. coli
Brown et al, 2009
Rev
c
0.067
µM /s
E. coli
Brown et al, 2009
Rxn
d
0.15
µM /s
E. coli
Brown et al, 2009
a
kcat
14.6
s
E. coli
Brown et al, 2009
b
5.3
s
E. coli
Brown et al, 2009
c
2.5
s
E. coli
Brown et al, 2009
d
5.7
s
E. coli
Brown et al, 2009
n
2.0
E. coli
Brown et al, 2009
a.
b.
c.
d.

Fbp fructose-1,6-bisphosphatase
YbhA fructose-1,6-bisphosphatase
YggF fructose-1,6-bisphosphatase
GlpX fructose-1,6-bisphosphatase

Reaction 18:

↔

Enzyme: Fructose-bisphosphate aldolase
Fructose-bisphosphate aldolase catalyzes the aldol cleavage of fructose-1,6bisphosphate into dihydroxyacetone phosphate and glyceraldehyde-3-phosphate.
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Forward Reaction:
Normal Michaelis-Menten kinetics were observed for the cleavage of fructose1,6-bisphosphate in E. coli (Plater et al, 1999). Equation (4) and the kinetic parameters
shown in Table XVIII were used to model this reaction.

Reverse Reaction:
The reverse reaction proceeds via a ping-pong mechanism (Lambeth &
Kushmerick, 2002). Equation (2) and the kinetic parameters in Table XVIII were used to
model the reverse reaction in SimBiology. Substrate A was dihydroxyacetone phosphate
and substrate B was glyceraldehyde-3-phosphate in the model.

Table XVIII. Kinetic parameters utilized for Reaction 18 in the model.
Parameter Value Units
Organism
Reference
Km
230
µM
E. coli
Plater et al, 1999
Fwd
kcat
0.07
s
E. coli
Plater et al, 1999
Rxn
KA
2100
µM
Rabbit
Lambeth & Kushmerick, 2002
Rev
KB
1100
µM
Rabbit
Lambeth & Kushmerick, 2002
Rxn
Vm
1733 µM /s
Rabbit
Lambeth & Kushmerick, 2002

Reaction 19:

↔

Enzyme: Triose phosphate isomerase
Triose phosphate isomerase catalyzes the conversion of dihydroxyacetone
phosphate into glyceraldehyde-3-phosphate via a cis-ene-diolate intermediate. Triose
phosphate isomerase is considered to be a perfect enzyme.
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Forward and Reverse Reaction:
The forward and reverse reactions are expressed by normal Michaelis-Menten
kinetics (Nickbarg & Knowles, 1988). Equation (4) and the parameters in Table XIX
were used to model the reaction.

Table XIX. Kinetic parameters utilized for Reaction 19 in the model.
Parameter
Value Units Organism
Reference
Km
2300
µM
E. coli
Nickbarg & Knowles, 1988
Fwd
Keq
750
µM
E. coli
Nickbarg & Knowles, 1988
Rxn
kcat
750
s
E. coli
Nickbarg & Knowles, 1988
Km
320
µM
Rabbit
Lambeth & Kushmerick, 2002
Rev
Rxn
Vm
200 µM /s
Rabbit
Lambeth & Kushmerick, 2002

Reaction 20:

↔

Enzyme: Glyceraldehyde-3-phosphate dehydrogenase
The enzyme glyceraldehyde-3-phosphate dehydrogenase catalyzes the reversible
oxidation of glyceraldehyde-3-phosphate into 1,3-diphosphateglycerate. The cofactor
NAD+ is reduced to NADH during the reaction.

Forward Reaction:
The forward reaction proceeds via a sequential ordered ter-bi mechanism (Wang
& Alaupovic, 1980). Ordered ter-bi reactions can be represented by the ordered ter-ter
kinetic expression for steady-state and rapid equilibrium kinetics (Purich & Allison,
2000). Equation (10) and the kinetic parameters found in Table XX were used to model
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the forward reaction in SimBiology. In the equation, substrate A was NAD+, substrate B
was glyceraldehyde-3-phosphate, and substrate C was inorganic phosphate.

(10)
[ ][ ][ ]

VMAX
KA
KB
KC
KiA
KiB
KiC
kcat
[A]
[B]
[C]
[E]

=
=
=
=
=
=
=
=
=
=
=
=

[ ][ ]

[ ][ ]

[ ]

[ ]

[ ]

kcat*[E] = [µM/s]
Dissociation constant for substrate A = [µM]
Dissociation constant for substrate B = [µM]
Dissociation constant for substrate C = [µM]
Binding constant for substrate A = [µM]
Binding constant for substrate B = [µM]
Binding constant for substrate C = [µM]
Maximum number of rxns catalyzed per second = [s-]
Concentration of substrate A = [µM]
Concentration of substrate B = [µM]
Concentration of substrate C = [µM]
Concentration of enzyme = [µM]

Table XX. Kinetic parameters utilized for Reaction 20 in the model.
Parameter Value
Units
Organism
Reference
KA
90
µM
Rabbit
Lambeth & Kushmerick, 2002
KB
290
µM
S. mutans
Crow & Wittenberger, 1979
Fwd
2.5
µM
Rabbit
Lambeth & Kushmerick, 2002
Rxn
KC
290
µM
Rabbit
Lambeth & Kushmerick, 2002
Vm
0.38
µM/s
S. mutans
Crow & Wittenberger, 1979
KA
0.8
µM
Rabbit
Lambeth & Kushmerick, 2002
Rev
KB
3.3
µM
Rabbit
Lambeth & Kushmerick, 2002
Rxn
Vm
21.08 µM /s
Rabbit
Lambeth & Kushmerick, 2002

Reverse Reaction:
The reverse reaction has a sequential ordered bi-ter mechanism (Wang &
Alaupovic, 1980). Ordered bi-ter reactions can be represented by the ordered bi-bi kinetic
expression for steady-state and rapid equilibrium kinetics (Purich & Allison, 2000).
Equation (3) and the kinetic parameters found in Table XX were used to model the

41
forward reaction in SimBiology. Substrate A was set as 1,3-diphosphateglycerate and
substrate B was set as NADH.

Reaction 21:

↔

Enzyme: Phosphoglycerate kinase
Phosphoglycerate kinase catalyzes the phosphoryl group transfer from 1,3diphosphateglycerate to ADP to form ATP and 3-phosphoglycerate.

Forward Reaction:
The forward reaction catalyzed by phosphoglycerate kinase follows a sequential
random bi-bi mechanism (Lavoinne et al, 1983). Equation (5) and the kinetic parameters
in Table XXI were used to model the reaction. Substrate binding was assumed to be
independent with substrate A as 1,3-diphosphateglycerate and substrate B as ADP.

Table XXI. Kinetic parameters utilized for Reaction 21 in the model.
Parameter Value Units Organism
Reference
KA
2.2
µM
Rabbit
Lambeth & Kushmerick, 2002
Fwd
KB
50
µM
Pig
Lambeth & Kushmerick, 2002
Rxn
Vm
18.7 µM/s
Pig
Lambeth & Kushmerick, 2002
KA
1200
µM
Pig
Lambeth & Kushmerick, 2002
Rev
KB
360
µM
Rabbit
Lambeth & Kushmerick, 2002
Rxn
Vm
18.7 µM/s
Pig
Lambeth & Kushmerick, 2002

Reverse Reaction:
The reverse reaction catalyzed by phosphoglycerate kinase also follows a
sequential random bi-bi mechanism (Lavoinne et al, 1983). Equation (5) and the kinetic
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parameters in Table XXI were used to model the reaction. Substrate binding was assumed
to be independent with substrate A as 3-phosphoglycerate and substrate B as ATP.

Reaction 22:

↔

Enzyme: Phosphoglycerate mutase
Phosphoglycerate mutase catalyzes the intramolecular phosphoryl group transfer
to form 2-phosphoglycerate from 3-phosphoglycerate. A histidine-phosphoenzyme
intermediate is formed during the reaction.

Forward and Reverse Reaction:
No kinetic mechanism was identified in the literature for Reaction 22; therefore,
normal Michaelis-Menten kinetics were assumed for the reaction in SimBiology.
Equation (4) and the kinetic parameters in Table XXII were used to model Reaction 22.

Table XXII. Kinetic parameters utilized for Reaction 22 in the model.
Parameter
Value
Units
Organism
Reference
Km
200
µM
E. coli dPGM
Fraser et al, 1999
210
µM
E. coli iPGM
Fraser et al, 1999
Fwd
kcat
330
s
E. coli dPGM
Fraser et al, 1999
Rxn
22
s
E. coli iPGM
Fraser et al, 1999
Km
190
µM
E. coli dPGM
Fraser et al, 1999
97
µM
E. coli iPGM
Fraser et al, 1999
Rev
Rxn
kcat
220
s
E. coli dPGM
Fraser et al, 1999
10
s
E. coli iPGM
Fraser et al, 1999

43
Reaction 23:

↔

Enzyme: Enolase
Enolase catalyzes the dehydration of 2-phosphoglycerate that produces the high
energy compound phosphoenolpyruvate.

Forward and Reverse Reaction:
No kinetic mechanism was identified for Reaction 23. Both reactions were
assumed to proceed via normal Michaelis-Menten kinetics. Equation (4) and the kinetic
parameters shown in Table XXIII were used to model the reaction in SimBiology.

Table XXIII. Kinetic parameters utilized for Reaction 23 in the model.
Parameter Value Units Organism
Reference
Km
100 µM
E. coli
Spring & Wold, 1971
Fwd
120 µM
Rat
Lambeth & Kushmerick, 2002
Rxn
Vm
3 µM/s
E. coli
Spring & Wold, 1971
Km
370 µM
Rat
Lambeth & Kushmerick, 2002
Rev
Rxn
Vm
3.2 µM/s
Rabbit
Lambeth & Kushmerick, 2002
Reaction 24:
Forward Reaction:

→

Enzyme: Pyruvate kinase
The forward reaction is catalyzed by pyruvate kinase and has been shown to have
a sequential random bi-bi mechanism (Giles et al, 1976; Waygood et al, 1976). Equation
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(5) and the kinetic parameters found in Table XXIV were used to model the reaction in
SimBiology. Substrate A was set as phosphoenolpyruvate and substrate B was set as
ADP.

Reverse Reaction:

→

Enzyme: Phosphoenolpyruvate synthetase
The reverse reaction is catalyzed by phosphoenolpyruvate synthetase and
proceeds via a ping-pong mechanism (Sigman, 1990). Equation (2) and the values in
Table XXIV were used in the model with substrate A as pyruvate and substrate B as
ATP.

Table XXIV. Kinetic parameters utilized for Reaction 24 in the model.
Parameter Value Units
Organism
Reference
KA
25
µM
E. coli
Valentini et al, 2000
80
µM
Rat
Lambeth & Kushmerick, 2002
KB
280
µM
E. coli
Valentini et al, 2000
Fwd
300
µM
Rat
Lambeth & Kushmerick, 2002
Rxn
kcat
103
s
E. coli
Valentini et al, 2000
110
s
E. coli
Valentini et al, 2000
KA
7050
µM
Rabbit
Lambeth & Kushmerick, 2002
Rev
KB
820
µM
Rabbit
Lambeth & Kushmerick, 2002
Rxn
Vm
24
µM/s
Rabbit
Lambeth & Kushmerick, 2002

Reaction 25:

→
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Enzyme: Phosphoenolpyruvate carboxykinase
Phosphoenolpyruvate carboxykinase catalyzes the irreversible conversion of
oxaloacetate into phosphoenolpyruvate via a sequential random bi-bi mechanism (Krebs
& Bridger, 1980). Equation (5) and the kinetic parameters shown in Table XXV were
used to model this reaction in SimBiology. Substrate binding was assumed to be
independent with substrate A as oxaloacetate and substrate B as ATP.

Table XXV. Kinetic parameters utilized for Reaction 25 in the model.
Parameter
Value
Units
Organism
Reference
KA
670
µM
E. coli
Krebs & Bridger, 1980
Fwd
KB
60
µM
E. coli
Krebs & Bridger, 1980
Rxn
Vm
0.02
µM/s
E. coli
Krebs & Bridger, 1980

Acetyl-CoA Synthesis

Acetyl-CoA synthesis is a metabolic pathway composed of one reaction. This
reaction is catalyzed by the enzyme complex pyruvate dehydrogenase as shown in Figure
5. This reaction converts pyruvate into acetyl-CoA with the help of the cofactor CoA.
This pathway was included in the model because of the use of acetyl-CoA as the starting
substrate in the PHB synthesis pathway.

Figure 5. The metabolic pathway for acetyl-CoA synthesis.
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Reaction 26:

→

Enzyme: Pyruvate dehydrogenase complex
The pyruvate dehydrogenase complex catalyzes an irreversible reaction to
produce acetyl-CoA from pyruvate, the product of glycolysis. It is a large, multienzyme
complex composed of three distinct types of enzyme. The pyruvate dehydrogenase
complex has several catalytic cofactors that include CoA, NAD+, thiamine pyrophosphate
(TPP), lipoamide, and FAD. The complex reaction can be broken down into four steps.

Step 1:
In the first step, pyruvate is decarboxylated after it combines with TPP. This stage
of the reaction is catalyzed by the pyruvate dehydrogenase component of the complex
(E1). This step exhibits tight-binding inhibition with thiamine 2-thiazolone diphosphate
(ThTDP), and with thiamine 2-thiothiazolone diphosphate (ThTTDP) (Liu & Bisswanger,
2003; Nemeria et al, 2001).

→

Step 2:
In the second step, the hydroxyethyl attached to the TPP is oxidized to form an
acetyl group that is transferred to lipoamide. This stage of the reaction is also catalyzed
by the pyruvate dehydrogenase component of the complex (E1) (Liu & Bisswanger,
2003; Nemeria et al, 2001).
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→

Step 3:
In the third step, the acetyl group is transferred from acetyllipoamide to CoA to
form acetyl-CoA. Dihydrolipoyl transacetylase (E2) catalyzes this step (Snoep et al,
1992; Willms et al, 1967).

→

Step 4:
In the fourth step, the oxidized lipoamide is regenerated using NAD+. This stage
of the reaction is catalyzed by dihydrolipoyl dehydrogenase (E3) (Allison et al, 1988).

→

Overall Reaction:
Kinetic studies on the pyruvate dehydrogenase complex from the bovine kidney
have demonstrated that the overall reaction fits a random bi-bi mechanism as well as the
Theorell-Chance mechanism (Butterworth et al, 1975).
In E. coli, studies have shown that the first step catalyzed by the E1 component of
the enzyme complex is the rate-limiting step (Liu & Bisswanger, 2003). MichaelisMenten kinetic parameters have been determined for the overall reaction in E. coli.
Equation (4) and the parameters in Table XXVI were used to model the overall reaction
in SimBiology.
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Table XXVI. Kinetic parameters utilized for Reaction 26 in the model.
Parameter
Value
Units
Organism
Reference
Km
321a
µM
E. coli
Liu & Bisswanger, 2003
356b
µM
E. coli
Liu & Bisswanger, 2003
Fwd
a
Vm
6.263
µM/s
E. coli
Liu & Bisswanger, 2003
Rxn
b
3.682
µM/s
E. coli
Liu & Bisswanger, 2003
a.
b.

H2O as solvent
D2O as solvent
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TRANSCRIPTIONAL NETWORK

The transcriptional network associated with the enzymes in the selected metabolic
pathways was included in the model. Enzymes are synthesized through the transcription
and translation of genes. Cells regulate the amount of enzymes synthesized depending
upon the needs of the cell. It is undesirable to waste energy synthesizing enzymes that are
not needed. Transcription factors are regulatory proteins that can repress or induce
transcription of genes. Cells use transcription factors to dynamically regulate the
intracellular concentration of enzymes (Lehninger et al, 2008).
The first step in modeling the transcriptional network was to identify all the genes
that contribute to the synthesis of the 30 enzymes used in Reactions 1-26. After the genes
were known, then the next step was to determine which promoters initiated transcription
of each gene. Next, the transcription factors associated with each promoter were
identified. Only promoters that interact with transcription factors were included in the
model. An equation was developed to calculate the rate of enzyme synthesis based on
promoter activity and the concentrations of each transcription factor. Each promoter was
represented by a reaction in the SimBiology model.
Ligand binding was also included in the model. Ligands that bind to each
transcription factor were identified. Rules were used in SimBiology to calculate the
concentration of active transcription factors based on the concentration of ligands.
Reactions were also included to account for the degradation of enzymes that occurs in the
cell. The end result of these equations and rules was a dynamic model of the
concentration of 30 enzymes based on a transcriptional network.
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Enzyme Genes and Promoters

The enzyme genes were determined using the EcoCyc database (ecocyc.org) and
the RegulonDB database (regulondb.ccg.unam.mx) for E. coli K12. These databases were
used to identify the promoters that initiate transcription of each gene, and the regulatory
proteins that activate or repress the transcription of each gene.
β-ketothiolase:
The gene phaA encodes for the enzyme β-ketothiolase that catalyzes Reaction 1.
The gene phaA is not naturally found in E. coli. The plasmid pBHR68 shown in Figure 6
has been used to insert phaA, phaB, and phaC into E. coli (Linton, 2010). These three
genes are transcribed using the lac promoter shown in Figure 6. The transcription factors
Crp, H-NS, and LacI help regulate lac as shown in Figure 7.

Figure 6. Summary diagram of the pBHR68 plasmid (Spiekermann et al, 1999).

Figure 7. Transcription regulation summary diagram for the lac promoter from EcoCyc.
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Acetoacetyl-CoA Reductase:
The gene phaB encodes for the enzyme acetoacetyl-CoA reductase that catalyzes
Reaction 2. The gene phaB is not found in the E. coli genome and is inserted using the
plasmid pBHR68 shown in Figure 6. The promoter associated with phaB is the lac
promoter. Figure 7 shows how Crp, H-NS, and LacI regulate the transcription of phaB.

Poly-β-hydroxybutyrate Polymerase:
The gene phaC encodes for the enzyme poly-β-hydroxybutyrate polymerase that
catalyzes Reaction 3. The gene phaC is added into E. coli by using the plasmid pBHR68
shown in Figure 6. The lac promoter and the three transcription factors shown in Figure 7
(Crp, H-NS, and LacI) regulate the transcription of phaC.

Citrate Synthase:
Citrate synthase is the enzyme that catalyzes Reaction 4, and it is encoded in the
E. coli genome by the gene gltA. The transcription factors that regulate the transcription
of gltA are Crp, IHF, and ArcA as shown in Figure 8. Figure 9 illustrates that there are
two promoters for gltA, but only the promoter gltAp1 is affected by the transcription
factors. Therefore, only the promoter gltAp1 was included in the model.

Figure 8. Transcription regulation summary diagram for the gene gltA from EcoCyc.
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Figure 9. Promoters and transcription factors for the gene gltA from EcoCyc.

Citrate Hydro-lyase:
The gene acnA encodes for the aconitase A enzyme that can catalyze Reaction 5
as citrate hydro-lyase. Figure 10 shows that transcription of acnA is regulated by the
transcription factors Crp, FruR, MarA, Rob, SoxS, ArcA, and Fnr. These transcription
factors activate or repress the promoter activity of acnAp2 as shown in Figure 11.

Figure 10. Transcription regulation summary diagram for the gene acnA from EcoCyc.

Figure 11. Promoter and transcription factors for the gene acnA from EcoCyc.
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The aconitase B enzyme that can also function as citrate hydro-lyase is encoded
by the gene acnB. Four transcription factors (Crp, ArcA, Fis, and FruR) regulate
transcription of acnB as illustrated by Figure 12. This gene is transcribed with the help of
two promoters (acnBp and acnBp2) as shown in Figure 13. However, the transcription
factors only regulate acnBp so the promoter acnBp2 was not included in the model.

Figure 12. Transcription regulation summary diagram for the gene acnB from EcoCyc.

Figure 13. Promoters and transcription factors for the gene acnB from EcoCyc.

Isocitrate Hydro-lyase:
Aconitase A is encoded by acnA and can also function as the enzyme isocitrate
hydro-lyase that catalyzes Reaction 6. See Figure 10 and Figure 11 for the promoter and
transcription factors involved with acnA.
The gene acnB encodes for the aconitase B enzyme that can also function as
isocitrate hydro-lyase. See Figure 12 for the transcription factors regulating acnB and see
Figure 13 for the promoters involved in the transcription of acnB.
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Isocitrate Dehydrogenase:
Isocitrate dehydrogenase catalyzes Reaction 7 and is encoded by the gene icd.
Transcription factors FruR and ArcA regulate the transcription of icd as illustrated by
Figure 14. ArcA represses the promoter icdAp1 and FruR activates the promoter icdAp2
as shown in Figure 15. Both promoters, icdAp1 and icdAp2, were included in the model.

Figure 14. Transcription regulation summary diagram for the gene icd from EcoCyc.

Figure 15. Promoters and transcription factors for the gene icd from EcoCyc.

2-Oxoglutarate Dehydrogenase:
The gene sucA encodes for the 2-oxoglutarate decarboxylase subunit of 2oxoglutarate dehydrogenase. This enzyme catalyzes Reaction 8 in the model.
Transcription of sucA is regulated by Crp, Fur, ArcA, Fnr, and IHF as shown in Figure
16. The promoter sucAp starts the transcription of sucA as illustrated by Figure 17.
The gene sucB encodes for the second subunit of 2-oxoglutarate dehydrogenase:
dihydrolipoyltranssuccinylase. The gene sucB is regulated by the same transcription
factors and promoters as sucA seen in Figure 16 and Figure 17.
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Figure 16. Transcription regulation summary diagram for the genes sucA, sucB, sucC,
and sucD from EcoCyc.

Figure 17. Promoter and transcription factors for the genes sucA, sucB, sucC, and sucD
from EcoCyc.

Lipoamide dehydrogenase is the third subunit of 2-oxoglutarate dehydrogenase
and is encoded by the gene lpd. This gene is regulated by the transcription factors Fis,
Crp, Fnr, Fur, ArcA, FruR, and PdhR as shown in Figure 18. The gene lpd has two
promoters initiating transcription: pdhRp and lpdAp. The promoter pdhRp is affected by
the transcription factors Crp, Fnr, and PdhR. The promoter lpdAp is regulated by ArcA,
Crp, Fis, Fnr, and Fur as illustrated in Figure 19.

Figure 18. Transcription regulation summary diagram for the gene lpd from EcoCyc.
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Figure 19. Promoters and transcription factors for the gene lpd from EcoCyc.

Succinyl-CoA Synthetase:
The enzyme succinyl-CoA synthetase is encoded by the genes sucC and sucD.
This enzyme catalyzes Reaction 9 in the model. These genes are regulated by the same
transcription factors and promoters as sucA and sucB. Figure 16 shows the transcription
regulation summary diagram and Figure 17 shows the promoters used to regulate
transcription of sucC and sucD.

Succinate Dehydrogenase:
The genes sdhA, sdhB, sdhC, and sdhD encode for the enzyme succinate
dehydrogenase that catalyzes Reaction 10. These four genes are regulated by Crp, Fur,
ArcA, and Fnr as seen in Figure 20. The promoters sdhCp and sdhDp2 are involved in the
transcription of these four genes. Figure 21 shows that the promoter sdhCp is regulated
by ArcA, Crp, Fur, and Fnr while the promoter sdhDp2 is only regulated by Crp. Both
promoters were included in the model of the transcriptional network.

Figure 20. Transcription regulation summary diagram for the genes sdhA, sdhB, sdhC,
and sdhD from EcoCyc.

57

Figure 21. Promoters and transcription factors for the genes sdhA, sdhB, sdhC, and sdhD
from EcoCyc.

Fumarase:
The gene fumA encodes for the fumarase A enzyme that catalyzes Reaction 11.
Figure 22 shows the transcription factors that regulate the transcription of fumA. ArcA
Crp, and Fnr regulate fumA through the promoter fumAp as shown in Figure 23.

Figure 22. Transcription regulation summary diagram for the gene fumA from EcoCyc.

Figure 23. Promoter and transcription factors for the gene fumA from EcoCyc.

Fumarase B is encoded by the gene fumB and can also catalyze Reaction 11. The
transcriptional regulation of fumB is more complex than fumA. Figure 24 shows that
ArcA, Crp, DcuR, Fnr, Fur, Fis, and NarL are all involved in regulating the transcription
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of fumB. The seven transcription factors regulate the transcription of fumB through three
promoters shown in Figure 25. Transcription factors ArcA, Fis, Fnr, and Fur are involved
with the promoter fumBp. Transcription factors Crp, Fnr, and NarL affect the promoter
dcuBp. The transcription factor DcuR activates promoter activity of dcuBp2.

Figure 24. Transcription regulation summary diagram for the gene fumB from EcoCyc.

Figure 25. Promoters and transcription factors for the gene fumB from EcoCyc.

The gen fumC encodes for fumarase C that can also catalyze Reaction 11. This
gene is regulated by seven transcription factors shown in Figure 26: MarA, Rob, SoxR,
SoxS, ArcA, Fnr, and Fur. These seven transcription factors regulate fumC through the
promoter fumCp shown in Figure 27.
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Figure 26. Transcription regulation summary diagram for the gene fumC from EcoCyc.

Figure 27. Promoter and transcription factors for the gene fumC from EcoCyc.

Malate Dehydrogenase:
Malate dehydrogenase catalyzes Reaction 12 and is encoded in the E. coli genome
by the gene mdh. The transcription factors Crp, DpiA, ArcA, and FlhCD regulate the
transcription of mdh as shown in Figure 28. Two promoters, mdhp1 and mdhp2, are
involved in the transcription of mdh as illustrated by Figure 29. All four transcription
factors impact mdhp1, whereas only DpiA affects mdhp2.

Figure 28. Transcription regulation summary diagram for the gene mdh from EcoCyc.
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Figure 29. Promoters and transcription factors for the gene mdh from EcoCyc.

Isocitrate Lyase:
Isocitrate lyase catalyzes Reaction 13 and is encoded by the gene aceA. The
transcription factors FruR, IHF, ArcA, Crp, and IclR regulate the transcription of aceA as
shown by Figure 30. These five transcription factors regulate transcription of aceA
through their interaction with the promoter aceBp shown in Figure 31.

Figure 30. Transcription regulation summary diagram for the genes aceA and aceB from
EcoCyc.

Figure 31. Promoter and transcription factors for the genes aceA and aceB from EcoCyc.
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Malate Synthase:
Malate synthase A is the enzyme that catalyzes Reaction 14 and is encoded by the
gene aceB. The transcription of aceB is under the same regulation as aceA. Figure 30
shows the five transcription factors and Figure 31 shows the promoter involved in the
transcription of aceB.
Malate synthase G can also catalyze Reaction 14. This isozyme is encoded by the
gene glcB. This gene is regulated by the transcription factors GlcC, IHF, and ArcA as
shown in Figure 32. There are two promoters involved in the transcription of glcB: glcBp
and glcDp. Figure 33 shows that only the promoter glcDp is affected by the transcription
factors; therefore, only glcDp was included in the model.

Figure 32. Transcription regulation summary diagram for the gene glcB from EcoCyc.

Figure 33. Promoters and transcription factors for the gene glcB from EcoCyc.

Glucokinase:
The enzyme glucokinase catalyzes Reaction 15 in the model. This enzyme is
encoded by the gene glk. The transcription of glk is regulated by the transcription factor
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FruR as shown in Figure 34. FruR represses the promoter activity of glkp as shown in
Figure 35. The promoter glkp1 is not affected by transcription factors and was not
included in the model.

Figure 34. Transcription regulation summary diagram for the gene glk from EcoCyc.

Figure 35. Promoters and transcription factor for the gene glk from EcoCyc.

Phosphoglucomutase:
The gene pgm encodes the enzyme phosphoglucomutase that catalyzes the first
step in the reverse direction of Reaction 15. This gene is regulated by HU as shown in
Figure 36. HU represses the activity of the seqAp promoter as shown in Figure 37.

Figure 36. Transcription regulation summary diagram for the gene pgm from EcoCyc.
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Figure 37. Promoter and transcription factor for the gene pgm from EcoCyc.

Glucose-1-Phosphatase:
Glucose-1-phosphatase catalyzes second step in the reverse direction of Reaction
15. This enzyme is encoded by the gene yihX. Figure 38 and Figure 39 show that no
transcription factors are known to regulate transcription of yihX. Therefore, this gene was
not included in the transcriptional network model.

Figure 38. Transcription regulation summary diagram for the gene yihX from EcoCyc.

Figure 39. Promoter for the gene yihX from EcoCyc.

Phosphoglucose Isomerase:
Phosphoglucose isomerase catalyzes Reaction 16 and is encoded by the gene pgi.
Transcription of pgi is regulated by the transcription factor SoxS as shown in Figure 40.
SoxS interacts with the promoter pgip as shown in Figure 41.

Figure 40. Transcription regulation summary diagram for the gene pgi from EcoCyc.
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Figure 41. Promoter and transcription factor for the gene pgi from EcoCyc.

6-Phosphofructokinase:
The gene pfkA encodes for the enzyme 6-phospofructokinase that catalyzes
Reaction 17. This gene is regulated by the transcription factor FruR as shown in Figure
42. The promoters pfkAp1 and pfkAp2 initiate transcription of pfkA as seen in Figure 43.
Only pfkAp2 interacts with FruR. Therefore, the promoter pfkAp1 was not included in the
model.

Figure 42. Transcription regulation summary diagram for the gene pfkA from EcoCyc.

Figure 43. Promoters and transcription factor for the gene pfkA from EcoCyc.

The gene pfkB also encodes for 6-phosphofructokinase. However, as seen in
Figure 44 and Figure 45, there are no transcription factors associated with the regulation
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of pfkB. Therefore, this gene was not included in the model of the transcriptional
network.

Figure 44. Transcription regulation summary diagram for the gene pfkB from EcoCyc.

Figure 45. Promoters for the gene pfkB from EcoCyc.

Fructose-1,6-Bisphosphatase:
The enzyme fructose-1,6-bisphosphatase that catalyzes the reverse direction of
Reaction 17 is encoded by the gene glpX. The transcription factors Crp and GlpR regulate
the transcription of glpX shown in Figure 46. GlpR and Crp regulate the gene by
interacting with the promoter glpFp shown in Figure 47.

Figure 46. Transcription regulation summary diagram for the gene glpX from EcoCyc.
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Figure 47. Promoter and transcription factors for the gene glpX from EcoCyc.

The gene ybhA also encodes for the enzyme fructose-1,6-bisphosphatase.
However, as seen in Figure 48 and Figure 49, no transcription factors or promoters are
known to regulate ybhA. Therefore, the gene ybhA was not included in the model.

Figure 48. Transcription regulation summary diagram for the gene ybhA from EcoCyc.

Figure 49. The gene ybhA from EcoCyc.

Another gene, yggF, also encodes for fructose-1,6-bisphosphatase. But, similar to
the gene ybhA, no transcription factors or promoters have been identified for yggF as
illustrated by Figure 50 and Figure 51.

Figure 50. Transcription regulation summary diagram for the gene yggF from EcoCyc.

Figure 51. The gene yggF from EcoCyc.
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Fructose-1,6-bisphosphatase is encoded by another gene, fbp. Figure 52 and
Figure 53 illustrate that no transcription factors or promoters are currently known to
regulate fbp.

Figure 52. Transcription regulation summary diagram for the gene fbp from EcoCyc.

Figure 53. The gene fbp from EcoCyc.

Fructose-Bisphosphate Aldolase:
Fructose-bisphosphate aldolase is the enzyme that catalyzes Reaction 18 and is
encoded by the gene fbaA. The transcription factors Crp and FruR regulate the
transcription of fbaA as shown in Figure 54. Four promoters are known to be associated
with the transcription of fbaA: epdp, pgkp1, pgkp2, and pgkp3. Figure 55 shows that only
the promoter epdp is affected by the transcription factors FruR and Crp. Therefore, epdp
was the only promoter included in the model.
Fructose-bisphosphate aldolase is also encoded by the gene fbaB. The gene fbaB
is regulated by the transcription factor FruR as shown in Figure 56. FruR interacts with
the promoter fbaBp as shown in Figure 57. The promoter fbaBp was included in the
transcriptional network model for the enzyme fructose-bisphosphate aldolase.

Figure 54. Transcription regulation summary diagram for the gene fbaA from EcoCyc.
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Figure 55. Promoters and transcription factors for the gene fbaA from EcoCyc.

Figure 56. Transcription regulation summary diagram for the gene fbaB from EcoCyc.

Figure 57. Promoter and transcription factor for the gene fbaB from EcoCyc.

Triose Phosphate Isomerase:
The gene tpiA encodes for the enzyme triose phosphate isomerase that catalyzes
Reaction 19. The gene tpiA is regulated by the transcription factor FruR as shown in
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Figure 58. There are two promoters that initiate transcription of tpiA, but only the
promoter tpiAp2 interacts with transcription factors as illustrated by Figure 59. Therefore,
only the promoter tpiAp2 was included in the transcriptional network model.

Figure 58. Transcription regulation summary diagram for the gene tpiA from EcoCyc.

Figure 59. Promoters and transcription factor for the gene tpiA from EcoCyc.

Glyceraldehyde-3-Phosphate Dehydrogenase:
The enzyme glyceraldehyde-3-phosphate dehydrogenase catalyzes Reaction 20
and is encoded by the gene gapA. The transcription factors Crp and FruR regulate the
transcription of gapA as shown in Figure 60. There are four promoters for the gene gapA
as shown in Figure 61. Only the promoters gapAp1 and gapAp3 interact with Crp and
FruR; therefore, only gapAp1 and gapAp3 were included in the model.
The genes gapC1 and gapC2 also encode for the enzyme glyceraldehyde-3phosphate dehydrogenase that catalyzes Reaction 20. The transcription of these two
genes is regulated by the protein Fnr as shown in Figure 62. Fnr regulates the
transcription of gapC1 and gapC2 through its interaction with the promoter gapC_1p
shown in Figure 63.
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Figure 60. Transcription regulation summary diagram for the gene gapA from EcoCyc.

Figure 61. Promoters and transcription factors for the gene gapA from EcoCyc.

Figure 62. Transcription regulation summary diagram for the genes gapC1 and gapC2
from EcoCyc.

Figure 63. Promoter and transcription factor for the genes gapC1 and gapC2 from
EcoCyc.
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Phosphoglycerate Kinase:
The gene pgk encodes for the enzyme phosphoglycerate kinase that catalyzes
Reaction 21. The transcription of pgk is regulated by Crp and FruR as shown in Figure
64. Four promoters initiate transcription of pgk as shown in Figure 65. Only the promoter
epdp is regulated; therefore, it was the only promoter included in the model.

Figure 64. Transcription regulation summary diagram for the gene pgk from EcoCyc.

Figure 65. Promoters and transcription factors for the gene pgk from EcoCyc.
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Phosphoglycerate Mutase:
Phosphoglycerate mutase catalyzes Reaction 22 and is encoded by the gene
gpmM. This gene is regulated by the transcription factor FruR as shown in Figure 66.
FruR regulates transcription of gpmM through its interactions with the promoter gpmMp
as shown in Figure 67.

Figure 66. Transcription regulation summary diagram for the gene gpmM from EcoCyc.

Figure 67. Promoter and transcription factor for the gene gpmM from EcoCyc.

The gene ytjC also encodes for the enzyme phosphoglycerate mutase. However,
as seen in Figure 68 and Figure 69, there are no known promoters and transcription
factors that regulate ytjC. Therefore, the gene ytjC was not included in the model.

Figure 68. Transcription regulation summary diagram for the gene ytjC from EcoCyc.

Figure 69. The gene ytjC from EcoCyc.

Another gene that encodes for phosphoglycerate mutase is gpmA. The
transcription of the gene gpmA is regulated by Fur through the promoter gmpAp as
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illustrated in Figure 70 and Figure 71. Since the second promoter gmpAp2 does not
interact with transcription factors, only the promoter gmpAp was included in the model.

Figure 70. Transcription regulation summary diagram for the gene gpmA from EcoCyc.

Figure 71. Promoters and transcription factors for the gene gpmA from EcoCyc.

Enolase:
The gene eno encodes for the enzyme enolase that catalyzes Reaction 23 in the
model. The transcription of eno is regulated by the transcription factor FruR as shown in
Figure 72. There are nine promoters that have been identified to initiate transcription of
eno as shown in Figure 73. Out of the nine promoters, only the promoters enop1, enop2,
and enop3 interact with the transcription factor FruR. Therefore, only the promoters
enop1, enop2, and enop3 were included in the transcriptional network model.

Figure 72. Transcription regulation summary diagram for the gene eno from EcoCyc.
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Figure 73. Promoters and transcription factor for the gene eno from EcoCyc.
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Pyruvate Kinase:
The enzyme pyruvate kinase catalyzes the forward direction of Reaction 24 and is
encoded by the gene pykF. The transcription of pykF is regulated by the protein FruR as
illustrated by Figure 74. The promoters pykFp, pykFp1, pykFp2, and pykFp3 initiate
transcription of pykF as shown in Figure 75. The only promoter that interacts with FruR
is pykFp; therefore, the promoter pykFp was the only one included in the transcriptional
network model.

Figure 74. Transcription regulation summary diagram for the gene pykF from EcoCyc.

Figure 75. Promoters and transcription factor for the gene pykF from EcoCyc.
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Pyruvate kinase is also encoded by the gene pykA. As seen in Figure 76, there are
no transcription factors known to regulate the transcription of pykA. Two promoters,
pykAp1 and pykAp2, are known to initiate transcription of pykA as shown in Figure 77.
Since there are no transcription factors involved, the gene pykA was not included in the
transcriptional network model.

Figure 76. Transcription regulation summary diagram for the gene pykA from EcoCyc.

Figure 77. Promoters for the gene pykA from EcoCyc.

Phosphoenolpyruvate Synthetase:
The gene ppsA encodes for the enzyme phosphoenolpyruvate synthetase that
catalyzes the reverse direction of Reaction 24. Figure 78 shows that FruR is the only
transcription factor that regulates ppsA. FruR interacts with the promoter ppsp as
illustrated by Figure 79.

Figure 78. Transcription regulation summary diagram for the gene ppsA from EcoCyc.
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Figure 79. Promoter and transcription factor for the gene ppsA from EcoCyc.

Phosphoenolpyruvate Carboxykinase:
The gene pck encodes for the enzyme phosphoenolpyruvate carboxykinase that
catalyzes Reaction 25. Transcription of the gene pck is regulated by the protein FruR as
shown in Figure 80. FruR regulates transcription by interacting with the promoter pckp as
shown in Figure 81.

Figure 80. Transcription regulation summary diagram for the gene pck from EcoCyc.

Figure 81. Promoter and transcription factor for the gene pck from EcoCyc.

Pyruvate Dehydrogenase:
The enzyme pyruvate dehydrogenase is a complex composed of three subunits.
The first subunit is encoded by the gene aceE. Figure 82 shows that transcription of aceE
is regulated by the proteins Crp, Fnr, ArcA, FruR, NsrR, and PdhR. The pdhRp and
aceEp promoters interact with these transcription factors as illustrated by Figure 83. Both
pdhRp and aceEp were included in the model.
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The second subunit of pyruvate dehydrogenase is encoded by the gene aceF. The
gene aceF is in the same operon as the gene aceE. See Figure 82 and Figure 83 for the
transcription factors and promoters that regulate transcription of aceF.
The gene lpd codes for the third subunit of pyruvate dehydrogenase that is
also a subunit of the enzyme 2-oxoglutarate dehydrogenase. See Figure 18 and Figure 19
for the transcription factors and promoters that regulate lpd.

Figure 82. Transcription regulation summary diagram for the genes aceE and aceF from
EcoCyc.

Figure 83. Promoters and transcription factors for the genes aceE and aceF from EcoCyc.

Transcription Regulatory Proteins

Transcription regulatory proteins are proteins that have a DNA binding domain
and regulate the transcription of genes. When the DNA binding domain is accessible,
these proteins bind to the DNA near promoters. If the regulatory protein is a repressor, it
interferes with the ability of the RNA polymerase to bind to the promoter and initiate
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transcription. If the protein is an activator, it increases the binding affinity between RNA
polymerase and the promoter in order to upregulate transcription of a gene (Lehninger et
al, 2008).
Transcription factors can be turned off or on through ligand binding. Ligand
binding induces a conformational shift that can either open or close the DNA binding
domain of the protein (Lehninger et al, 2008). In order to correctly model the
transcriptional network, it was important to understand when and how the regulatory
proteins became active transcription factors. This section explains the interactions with
ligands and the specific regulatory proteins identified in this model. A summary chart of
the transcription factors used in this model is available in Appendix A.

ArcA:
ArcA is a transcriptional regulatory protein that is capable of binding to DNA
when phosphorylated by the kinase ArcB. Phosphorylated ArcA acts as a repressor by
binding to promoters or activator binding sites (Jeon et al, 2001). ArcA-P is a
transcriptional repressor for many of the TCA cycle and glyoxylate enzymes under
anaerobic conditions (Gunsalus & Park, 1994). ArcA acts as a transcriptional activator
for a small number of genes by being part of a nucleoprotein complex (Sawers &
Suppmann, 1992).

Crp:
The Crp transcriptional regulator, also known as CAP, can bind to DNA only
when activated by cAMP. In the absence of glucose, cAMP-Crp levels rise allowing
more Crp to bind to DNA (Ishizuka et al, 1994). Crp generally acts as a transcriptional
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activator by binding upstream of the polymerase binding site. However, it can also act as
a repressor by occupying the binding site of an activator protein or by interfering with the
promoter region (Kolb et al, 1993; Liu et al, 2004).

DcuR:
The DcuR regulatory protein is activated for DNA binding through
phosphorylation by kinase DcuS. Upon phosphorylation of an aspartate residue, DcuR
dimerizes and is capable of binding to DNA to activate transcription (Golby et al, 1999).

DpiA:
DpiA is a transcriptional regulator that can bind to DNA when phosphorylated on
an aspartate residue. It binds to DNA sequences rich in A and T nucleotides. DpiA-P is a
transcriptional activator of malate dehydrogenase when citrate is available in an
anaerobic environment (Yamamoto et al, 2008).

Fis:
Fis is a small protein capable of tight binding to DNA when dimerized (Finkel &
Johnson, 1992). One study indicated that approximately 21% of genes are regulated by
Fis (Cho et al, 2008). Fis requires no modifications to bind to DNA.

FlhDC:
FlhD and FlhC are proteins that can form the heterotetramer FlhD2C2. As a
heterotetramer, FlhDC can bind to DNA and act as a transcriptional repressor or
activator. No inducer has been observed for FlhDC (Stafford et al, 2005).
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Fnr:
Fnr is a protein that activates genes needed for anaerobic metabolism and
represses genes used for aerobic metabolism. The concentration of Fnr remains
approximately the same under aerobic and anaerobic conditions (~3.7 µM) (Sutton et al,
2004). The DNA-binding activity of Fnr is regulated by oxygen. In the absence of
oxygen, a [4Fe-4S] cluster binds to Fnr allowing the protein to dimerize. As a dimer, Fnr
can bind to DNA and activate or repress transcription. In the presence of oxygen, the
[4Fe-4S] cluster is oxidized into [2Fe-2S] that destabilizes the dimer (Sutton et al, 2004).

FruR:
FruR is a transcriptional regulator also known as Cra. Unmodified FruR can bind
to DNA and can activate transcription of genes in the TCA cycle, the glyoxylate
pathways, and gluconeogenesis. FruR acts as a repressor for genes involved in glycolysis.
Fructose-1,6-bisphosphate and fructose-1-phosphate can bind with FruR and prevent
FruR from binding to DNA (Ramseier et al, 1995).

Fur:
Fur is a transcriptional activator and repressor that can only bind to DNA with the
cofactor Fe2+. Fur is a regulator of many genes including some involved in the TCA
cycle, glycolysis, and gluconeogenesis (Mills & Marletta, 2005).

GlcC:
GlcC is a dual transcriptional regulator that can bind to DNA when induced by
glycolate. It regulates genes needed when glycolate is the main carbon source (Pellicer et
al, 1999).
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GlpR:
GlpR is a transcriptional repressor that can bind to DNA in its unmodified form.
Binding of either glycerol or glycerol-3-phosphate to GlpR causes a conformational shift
that interferes with DNA binding (Lin, 1976).

H-NS:
Histone-like nucleoid structuring protein (H-NS) is a small DNA-binding protein
used to condense and supercoil DNA. It acts as a transcription factor for several genes,
and has so far only been identified as a repressor with no inducer (Oshima et al, 2006).

HU:
HU is a transcriptional dual regulator. It is a small DNA-binding protein similar to
histones and helps supercoil DNA. It can bind to DNA and act as a transcriptional
activator or repressor without an inducer (Oberto et al, 2009).

IclR:
IclR is a transcriptional repressor that regulates enzymes in the glyoxylate shunt.
Pyruvate and glyoxylate can bind to IclR. Pyruvate stabilizes the active tetrameric form
that can bind to DNA while glyoxylate stabilizes the inactive dimer form that cannot bind
to DNA (Lorca et al, 2007).

IHF:
IHF is a protein that is highly abundant in cells, and is used as both a
transcriptional repressor and activator. IHF often stabilizes correct nucleoprotein
complexes and can facilitate the formation of loops near the promoter. It is a heterodimer
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protein that binds to A/T rich sequences of DNA. IHF requires no inducer to bind to
DNA (Azam et al, 1999).

LacI:
LacI is an inducible transcriptional repressor for the lac operon. Unmodified LacI
can bind to DNA at two operators forming a repressor loop to reduce transcription.
Allolactose, or IPTG, can bind to LacI and cause a conformational shift that prevents
LacI from binding to DNA (Lewis, 2005).

MarA:
MarA is a dual transcriptional regulator similar to SoxS and Rob. MarA binds to a
specific DNA sequence known as the sox-mar-rob box. MarA requires no inducer to bind
to DNA (Martin et al, 2008).

NarL:
NarL is a nitrate/nitrite response regulator that can activate and repress
transcription of genes needed for nitrate respiration and other pathways. In the presence
of nitrate or nitrite, the kinase NarX phosphorylates NarL. Phosphorylated NarL is
capable of binding to DNA. In the absence of nitrate and nitrite, NarL is inactivated by
dephosphorylation (Schröder et al, 1994).

NsrR:
NsrR is a nitrate-sensitive repressor that regulates at least 30 genes. NsrR can only
bind to DNA with the cofactor [2Fe-2S] cluster. If nitric oxide (NO) binds to the [2Fe-
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2S] cluster, then NsrR can no longer bind to DNA (Tucker et al, 2008). Ammonium
nitrate is a usable nitrogen source for PHB production (Khanna & Srivastava, 2005).

PdhR:
PdhR is a transcriptional repressor for genes coding the pyruvate dehydrogenase
and 2-oxoglutarate dehydrogenase complexes. Unmodified PdhR can bind to DNA to
repress transcription. Pyruvate can bind to PdhR and cause a conformational shift that
prevents PdhR from binding to target promoters (Quail & Guest, 1995).

Rob:
Rob is a transcriptional activator similar to SoxS and MarA and binds to the soxmar-rob box. No inducer is needed for Rob to bind to DNA (Martin et al, 2008).

SoxR:
SoxR is a transcriptional activator that is activated by the cofactor [2Fe-2S]
cluster. SoxR can bind to DNA with or without [2Fe-2S], but is only able to activate
transcription with the presence of a [2Fe-2S] cluster (Gaudu & Weiss, 1996).

SoxS:
SoxS is a transcriptional activator sensitive to superoxide and nitric oxide. SoxS is
similar to Rob and MarA and binds to the sox-mar-rob box DNA sequence (Martin et al,
2008). Activity of SoxS is controlled solely by its concentration (Griffith et al, 2004).
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Transcriptional Network Equations

The metabolic pathways modeled consist of many enzymatic reactions. These
enzymatic reactions are intrinsically dependent upon the concentration of the enzymes.
The concentration of enzymes in a cell is dependent upon the quantity being transcribed
and translated from the DNA coupled with the rate of enzyme degradation. Expressions
were used to relate enzyme concentration to promoter activity and transcription factors.
The concentration of transcription factors was related to the frequency of ligand binding.
Enzyme degradation was correlated to the amino acid on the N-terminus of the enzyme’s
polypeptide. The following equations were used to model the concentration of enzymes
based on their transcriptional network.

Enzyme Concentration:
An equation was needed to correlate the amount of enzyme synthesized to its
transcription factors and promoters. Equation (11) describes enzyme concentration as a
function of the concentration of a single transcription factor (Ronen et al, 2002; Zaslaver
et al, 2004). However, enzymes are usually regulated by multiple transcription factors.

dE


dt 1  TF

 k

E
β
TF
k
H

=
=
=
=

H

Enzyme concentration
Promoter activity (unrepressed/inactivated)
Transcription factor concentration
Effective affinity of the transcription factor
(Conc. for half maximal repression/activation)
= Hill coefficient of cooperativity
H > 0 = repression
H < 0 = activation

(11)
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Equation (11) was modified as part of this thesis development to include terms for
multiple transcription factors affecting one promoter. Equation (12) was the result and it
relates enzyme concentration to the concentrations of n transcription factors. This
equation calculates the enzyme concentration based on all of the activators and repressors
that interact with the promoter that initiates transcription of the enzyme’s gene.
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Enzyme concentration
Promoter activity (unrepressed/inactivated)
Transcription factor n concentration
Effective affinity of transcription factor n
(Conc. for half maximal repression/activation)
= Hill coefficient of cooperativity
H > 0 = repression
H < 0 = activation

Each promoter found to be regulated by transcription factors was represented by a
reaction as shown in Figure 84. The rate for each promoter reaction was based on
Equation (12). Forty promoters were used to model the transcription of 29 enzymes as
seen in Figure 84. The transcription factors that regulate each promoter are shown as
substrates to the promoter reactions, with enzymes shown as products of the reaction.
Eight of the promoters initiate transcription of more than one enzyme, so multiple
enzymes are shown as products of those reactions. Thirteen of the enzymes are impacted
by multiple promoters, so they are shown as products of multiple promoter reactions.
Table XXVII contains values from the literature that were used for the transcription
factor terms in Equation (12) for each promoter reaction.
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Figure 84. SimBiology model diagram of enzyme and transcription factor interactions.
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Table XXVII. Transcription factor concentrations [TF] and effective affinity values (kn).
TF
[TF] µM
kn
Organism
Reference
ArcA
NA
0.25-0.6
E. coli
Shen & Gunsalus, 1997
Crp
3.3-9.4
NA
E. coli
Ishizuka et al, 1993
DcuR
0.7-1.7
6
E. coli
Abo-Amer et al, 2004
Fis
0.17
NA
E. coli
Azam et al, 1999
Fnr
3.7
NA
E. coli
Sutton et al, 2004
Fur
8.3-16.6
NA
E. coli
Zheng et al, 1999
H-NS
13
NA
E. coli
Azam et al, 1999
HU
50
NA
E. coli
Azam et al, 1999
IHF
42
NA
E. coli
Azam et al, 1999
LacI
0.033
NA
E. coli
Zheng et al, 1999
MarA
0.067
0.02
E. coli
Martin et al, 1996
NarL
NA
0.9-1.4
E. coli
Darwin et al, 1997
NsrR
NA
0.02
N. gonorrhoeae
Isabella et al, 2009
PdhR
0.61
0.005
E. coli
Quail & Guest, 1995
Rob
17
NA
E. coli
Azam et al, 1999
SoxR
0.17
0.045
E. coli
Hidalgo & Demple, 1994
Pomposiello & Demple, 2001
SoxS
0.2
0.015
E. coli
Li & Demple, 1994
Martin et al, 1996
Active Transcription Factor Concentration:
Transcription factors are proteins with DNA binding domains that allow the
protein to regulate transcription of certain genes. The DNA binding domain can be made
more or less accessible by the binding of ligands to the transcription factor. The
concentration of active transcription factor is the amount of the transcription factor that
has the DNA binding domain accessible. Equation (13) shows how the fraction of
bindings sites bound with a ligand is dependent upon the ligand concentration.
[ ]
[ ]

L = Ligand concentration
Kd = Dissociation constant
θ = Fraction of binding sites bound with ligand

(13)
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The transcription factors FruR, GlpR, PdhR, LacI, and IclR have DNA binding
domains that are made less accessible when a specific ligand binds to the transcription
factor. For these transcription factors, Equation (14) was used to calculate the active
transcription factor concentration in the model. In the model, Equations (13) and (14)
were entered as Rules to calculate the active concentration of FruR, GlpR, PdhR, LacI,
and IclR at each time step.

TFA = (1-θ)*[TF]

(14)

TFA = Active transcription factor concentration
θ = Fraction of binding sites bound with ligand
TF = Total transcription factor concentration

ArcA, CRP, DcuR, DpiA, Fnr, Fur, GlcC, IclR, NarL, NsrR, and SoxR are
transcription factors that need a specific ligand bound in order to open up the DNA
binding domain. Equations (13) and (15) were used to calculate the active transcription
factor concentration in the model for transcription factors that require ligand-binding.
Rules were used to evaluate the two equations at each time step for these 11 transcription
factors.
TFA = θ*[TF]

(15)

TFA = Active transcription factor concentration
θ = Fraction of binding sites bound with ligand
TF = Total transcription factor concentration

The DNA binding domains have not yet been found to be affected by ligandbinding for the transcription factors Fis, FlhDC, H-NS, HU, IHF, MarA, Rob, and SoxS.
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The active transcription factor concentration was set equal to the total transcription factor
concentration for these regulatory proteins. Table XXVIII shows values found in the
literature for ligand concentrations that were used in the model. The model diagram for
the interactions between transcription factors and ligands is shown in Figure 85.

Table XXVIII. Known values for ligand concentrations used in the model.
Ligand
[L] µM
Organism
Reference
10-70
E. coli
Makman & Sutherland, 1965
cAMP
28
E. coli
Krishna et al, 2009
4200
S. cerevisiae
Hynne et al, 2001
Glycerol
100
E. coli
Linton, 2010
IPTG
2440
H. sapiens
Nazaret et al, 2009
7000
T. brucei
Helfert et al, 2001
Pi
6500
S. cerevisiae
Teusink et al, 2000
12000
S. cerevisiae
Nielsen et al, 1998

Figure 85. SimBiology model diagram of ligand and transcription factor interactions.
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Enzyme Degradation:
The intracellular concentration of an enzyme is dependent upon the amount
synthesized and degraded. Enzyme synthesis is represented in this model by the
transcriptional network. Degradation reactions were added to the model to prevent
constant accumulation of enzyme concentrations.
Degradation reactions were modeled using simple-mass action kinetics with the
rate constant calculated from the enzyme half-life as shown in Equation (16). Enzyme
half-lives were estimated based on the N-end rule (Varshavsky, 1997). Enzyme half-lives
have a rough correlation with the amino acid on the N-terminus of the polypeptide chain.
( )

(16)

r = Degradation rate
τ = Enzyme half-life

The N-terminal amino acid was determined for each enzyme and the degradation
rate was calculated from the half-life determined from the N-end rule. Figure 86 shows
the model diagram for the enzyme degradation reactions. Because degradation rates are
only estimates, these values were adjusted later on to achieve the best fit to published
models.
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Figure 86. SimBiology model diagram of enzyme degradation reactions.
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METABOLIC PROFILING

Introduction

Metabolic profiling is the process of monitoring the concentration of specific
metabolites over time. The resulting data can be used to adjust parameters in order to
create a more accurate model of the metabolic pathways in a specific strain of bacteria.
Metabolic profiling requires culture samples to be quenched at specific time intervals.
Quenching provides metabolic concentrations at a given time. One of the most common
quenching methods is to shock the samples with a cold-buffered aqueous methanol
mixture (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006; Lu et al, 2008;
Mashego et al, 2007; Ohashi et al, 2007).
After sample preparations, metabolite concentrations can be determined through
combinations of liquid chromatography (LC), gas chromatography (GC), mass
spectrometry (MS), capillary electrophoresis (CE), and nuclear magnetic resonance
(NMR) (Bajad et al, 2006; Buchholz et al, 2001; Dettmer et al, 2006; Lu et al, 2008;
Mashego et al, 2007; Ohashi et al, 2007). Liquid chromatography combined with mass
spectrometry (LC-MS) is effective because it can use a small sample volume to
determine the concentrations of many metabolites simultaneously. One study was able to
analyze the concentration of 69 metabolites from a single sample (Bajad et al, 2006).
The data obtained from metabolic profiling can be incorporated into the predictive
model to allow a more precise simulation of the metabolic pathways under analysis.
Metabolic profiling can continue to be used in the iterative process of genetically
engineering an optimized PHB producing strain of bacteria.
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Materials and Methods

Strains and Culture Methods:
E. coli XL1-Blue cells containing the pBHR68 plasmid have been shown to
accumulate as much as 55% of their cell dry weight as bio-plastic (Linton, 2010).
Analysis of the metabolomics was conducted on samples from this cell line and a control
study was performed using untransformed E. coli XL1-Blue cells. The control study used
the same procedures outlined below with the exception of adding ampicillin to the growth
media.
Cells were pre-cultured by inoculating 5 mL of M9 growth media with 50 µL of a
frozen glycerol stock. The M9 growth media was supplemented with 50 µg/mL
ampicillin for selection of cells harboring the pBHR68 plasmid. Cultures were grown for
10 hours and then used to inoculate a second culture in 5 mL of M9 growth media (1:100
v/v). The second culture was grown for 10 hours and then used to inoculate a third
culture in 5 mL of M9 growth media (1:100 v/v). The third culture was grown for 10
hours and then used to inoculate 150 mL M9 growth media (1:100 v/v) containing 1%
(w/v) glucose and 50 µg/mL ampicillin. Cells were grown to stationary phase, and then
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1
mM. Additional glucose, 15 mL of 7.5% (w/v) glucose solution, was added 5 hours after
inoculation. Starting 5 hours after inoculation, 0.5 mL samples were taken every 15
minutes until cell growth reached stationary phase. Absorbance of the cultures was
recorded at 600 nm every 30 minutes to monitor cell growth.
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Quenching and Sample Preparation:
The samples were quenched for metabolic activity by adding 2.5 mL of -50o C
aqueous methanol (60% v/v) containing 70 mM Hepes buffer (Bajad et al, 2006).
Samples were sonicated for 2 minutes while kept on ice in order to lyse the cells.
Samples were lyophilized using a speed vacuum and then re-suspended in 300 µL of
quenching fluid in order to concentrate the samples. Then the samples were centrifuged
for 10 minutes at 10,286g. Cell pellets were discarded and then the supernatant was
stored at -80o C. All samples were stored for future analysis by high performance liquid
chromatography and mass spectrometry (HPLC-MS). Recommended analytical methods
for HPLC-MS are outlined in Appendix B.

Results

Growth curves obtained from the optical density for the two strains of E. coli are
shown in Figure 87. After IPTG was added, the strain with the pBHR68 plasmid showed
slower cell growth than the other strain as seen in Figure 87. Slower cell growth after
induction by IPTG is consistent with the hypothesis that energy is being diverged from
normal cellular functions in order to synthesize PHB.
Metabolic profiling data was not obtained due to the unavailability of a
functioning mass-spectrometer. Metabolic profiling samples were stored at -80o C for
future analysis. It was anticipated that the metabolic profiling data would be used to
better fit the predictive model to the specific strain of E. coli under study. Because this
data was unavailable, the model was fit to nine published models and to preliminary PHB
production data as shown in the next chapter.
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Figure 87. Natural log of the absorbance at time t divided by (A) the initial absorbance
reading and (B) absorbance reading at t = 5 hr plotted over time. Absorbance was read at
600 nm. At t = 5 hr, 15 mL of 5 x glucose solution was added to both cultures and IPTG
was added to a final concentration of 0.1 mM in the XL1-Blue + pBHR68 culture. Error
bars represent standard error with n = 3.
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SIMULATIONS AND RESULTS

Comparing Model with Literature

The glycolysis and TCA portions of the SimBiology model were validated using
published models found in the BioModels database at http://www.ebi.ac.uk/biomodelsmain/publ-models.do. This database is a compilation of published models assembled by
the European Bioinformatics Institute. Out of 366 curated BioModels, seven were
identified as glycolysis models and two were identified as TCA cycle models. These nine
models were used to validate the glycolysis pathway and the TCA cycle modeled in
SimBiology.

Glycolysis BioModels:
Seven BioModels including 42, 61, 64, 71, 172, 176, and 177 were used to
validate the glycolysis portion of the predictive model. The online simulator in the
BioModels database was used to run simulations of the species in glycolysis. The
SimBiology model was adjusted to match its steady-state concentrations with the steadystate concentrations of the glycolysis intermediates simulated in the BioModels. The first
two BioModels (42 and 61) modeled glycolytic oscillations observed in synchronous
cultures. The SimBiology model is not a model for synchronous cultures; therefore, the
SimBiology model was adjusted to match the average steady-state concentrations of the
glycolysis species for these two BioModels.
The SimBiology model needed to be altered to accurately match these seven
BioModels. The BioModels do not account for PHB synthesis; therefore, the PHB
synthesis pathway was shut off in the model by inactivating the forward and reverse
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directions of Reaction 1. To account for diffusion of extracellular glucose into the cell,
Reaction 0 was created using simple mass action kinetics. Reaction 27 was added to
account for pyruvate used elsewhere in the cell and Reaction 28 was created to account
for acetyl-CoA used in pathways not included in the model. Reactions 27 and 28 were
modeled using simple mass action kinetics.
None of the BioModels accounted for the transcriptional network. Therefore, the
transcriptional network portion of the SimBiology model was inactivated by holding the
enzyme concentrations constant. All of the seven BioModels identified above simulated
continuous cultures, so the concentration of extracellular glucose was held constant in the
predictive model. The concentrations of ATP, ADP, NAD+, and NADH were also held
constant during simulation. Initial concentrations of glycolysis substrates were changed
to match the initial values used in each BioModel. The value zero was used for any initial
concentration not specified in the BioModel. The values for Reaction 0, Reaction 27,
Reaction 28, and the glycolysis enzyme concentrations were adjusted until the
SimBiology simulations matched the simulations from the BioModel.

Reaction 0:
→

Reaction 27:
→

Reaction 28:
→
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BioModel 42 - Nielsen 1998 Glycolysis:
BioModel 42 is a glycolysis model for S. cerevisiae (Nielsen et al, 1998). This
model simulates observed oscillations in a continuous-flow, stirred tank reactor.
Glycolytic oscillations in yeast are a result of a synchronous culture. BioModel 42 used
the initial concentrations shown in Table XXIX. In order to fit the SimBiology model to
BioModel 42, the values in Table XXIX were used as initial concentrations in the
SimBiology model.
Twelve variables were adjusted in order to match the simulations between the
SimBiology model and BioModel 42. Two of the variables were reaction rates for
Reaction 0 and Reaction 27. The other ten variables were the glycolysis enzyme
concentrations. Table XXIX shows the enzyme concentrations and reaction rates used to
successfully fit the model. Figure 88 and Figure 89 visually compare the simulations
from BioModel 42 with the adjusted SimBiology model.

A

B

Figure 88. Simulations from (A) BioModel 42 and (B) SimBiology model for the species
glucose, fructose-6-phosphate, fructose-1,6-bisphosphate, and 1,3-diphosphoglycerate.
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A

B

Figure 89. Simulations from (A) BioModel 42 and (B) SimBiology model for the species
glyceraldehyde-3-phosphate, phosphoenolpyruvate, and pyruvate.

Table XXIX. Initial substrate concentrations, enzyme concentrations, and reaction rates
used to compare the SimBiology model to BioModel 42.
Species
Value
Unit
Reference
GLC_ex
6000
µM
Nielsen et al, 1998
GLC
11.3
µM
Nielsen et al, 1998
G6P
0
µM
---F6P
659
µM
Nielsen et al, 1998
FBP
7.7
µM
Nielsen et al, 1998
Initial
GAP
1.9
µM
Nielsen et al, 1998
Concentrations
DHAP
0
µM
---of Glycolysis
DPG
299
µM
Nielsen et al, 1998
Substrates
3PG
0
µM
---2PG
0
µM
---PEP
2.1
µM
Nielsen et al, 1998
PYR
4.2
µM
Nielsen et al, 1998
KIN
310
µM
---PGI
50
µM
---6PFK
0.8328
µM
---FBA
880.33
µM
---Enzyme
TPI
0.56
µM
---Concentrations
GAD
351.7
µM
---Used to Fit Model
PGK
6.65045
µM
---PGM
2.06
µM
---ENO
420
µM
---PYK
2.52
µM
---R0
0.01
µM/s
---Reaction Rates
Used to Fit Model
R27
1.17
µM/s
----
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BioModel 61 - Hynne 2001 Glycolysis:
BioModel 61 is another model for glycolysis in S. cerevisiae (Hynne et al, 2001).
Similar to BioModel 42, this model simulates glycolytic oscillations in yeast. BioModel
61 used the initial species concentrations found in Table XXX. The values in Table XXX
were used as initial substrate concentrations to fit the SimBiology model to BioModel 61
Many different values for ten enzymes and two reaction rates were tried in order
to successfully fit the model to BioModel 61. Table XXX shows the combination of
values that resulted in a successful fit to BioModel 61. The matching simulations between
the model and BioModel 61 are shown in Figure 90, Figure 91, and Figure 92.
BioModel 61 did not have simulations available for the species 2phosphoglycerate and 3-phosphoglycerate. The average simulation value from the other
BioModels for 2-phosphoglycerate was 0.062 mM. The average simulation value for 3phosphoglycerate was 0.48 mM. For these two species, the SimBiology model was fit to
match the average values as shown in Figure 93.

A

B

Figure 90. Simulations from (A) BioModel 61 and (B) SimBiology model for the species
glucose intracellular, glucose extracellular, and pyruvate.
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B

A

Figure 91. Simulations from (A) BioModel 61 and (B) SimBiology model for the species
dihydroxyacetone phosphate, fructose-1,6-bisphophosphate, fructose-6-phosphate, and
glucose-6-phosphate.

A

B

Figure 92. Simulations from (A) BioModel 61 and (B) SimBiology model for the species
1,3-diphosphoglycerate, glyceraldehyde-3-phosphate, and phosphoenolpyruvate.
BioModel 64 – Teusink 2000 Glycolysis:
BioModel 64 is another glycolysis model for S. cerevisiae (Teusink et al, 2000).
This model simulates steady-state fluxes in a continuous fed reactor. Unlike BioModel 42
and 61, this BioModel does not model glycolytic oscillations. The initial species
concentrations in Table XXXI were used in BioModel 64 and in the SimBiology model.

103

Figure 93. Simulation from SimBiology model for the species 2-phosphoglycerate and 3phosphoglycerate. BioModel 61 had no simulations for these species.

Table XXX. Initial substrate concentrations, enzyme concentrations, and reaction rates
used to compare the SimBiology model to BioModel 61.
Species
Value
Unit
Reference
GLC_ex
24000
µM
Hynne et al, 2001
GLC
573
µM
Hynne et al, 2001
G6P
4200
µM
Hynne et al, 2001
F6P
490
µM
Hynne et al, 2001
FBP
4640
µM
Hynne et al, 2001
Initial
GAP
115
µM
Hynne et al, 2001
Concentrations
DHAP
2950
µM
Hynne et al, 2001
of Glycolysis
DPG
0.27
µM
Hynne et al, 2001
Substrates
3PG
0
µM
---2PG
0
µM
---PEP
40
µM
Hynne et al, 2001
PYR
8700
µM
Hynne et al, 2001
KIN
310
µM
---PGI
50
µM
---6PFK
4.0
µM
---FBA
3585
µM
---Enzyme
TPI
0.56
µM
---Concentrations
GAD
1427
µM
---Used to Fit Model
PGK
150
µM
---PGM
2.06
µM
---ENO
420
µM
---PYK
9.0
µM
---R0
0.01
µM/s
---Reaction Rates
Used to Fit Model
R27
0.022
µM/s
----
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Different combinations of enzyme concentrations and reaction rate values were
simulated in the SimBiology model. The values found in Table XXXI were a successful
combination that resulted in a good fit to BioModel 64. Figure 94 and Figure 95 show
how closely the SimBiology model simulations matched the BioModel 64 simulations.
BioModel 64 had no simulations available for glyceraldehyde-3-phosphate and
dihydroxyacetone phosphate. The average concentration for glyceraldehyde-3-phosphate
from other BioModels was 2.14 mM. The average concentration for dihydroxyacetone
phosphate from BioModels 71, 172, 176, and 177 was 0.032 mM. The SimBiology model
was adjusted to match these average values as shown in Figure 96.

A

B

Figure 94. Simulations from (A) BioModel 64 and (B) SimBiology model for the species
3-phosphoglycerate, fructose-1,6-bisphosphate, glucose-6-phosphate, and pyruvate.

BioModel 71 - Bakker 2001 Glycolysis:
BioModel 71 simulates glycolysis in the protist species T. brucei (Helfert et al,
2001). Like the other glycolysis BioModels, this one also models a continuous fed
reactor. Initial substrate concentrations in the SimBiology model were set to match the
initial concentrations in BioModel 71 shown in Table XXXII.
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A

B

Figure 95. Simulations from BioModel 64 for the species 1,3-diphosphoglycerate, 2phosphoglycerate, fructose-6-phosphate, glucose intracellular, and phosphoenolpyruvate.

Table XXXI. Initial substrate concentrations, enzyme concentrations, and reaction rates
used to compare the SimBiology model to BioModel 64.
Species
Value
Unit
Reference
GLC_ex
50000
µM
Teusink et al, 2000
GLC
87
µM
Teusink et al, 2000
G6P
2450
µM
Teusink et al, 2000
F6P
620
µM
Teusink et al, 2000
FBP
5510
µM
Teusink et al, 2000
Initial
GAP
0
µM
---Concentrations
DHAP
0
µM
---of Glycolysis
DPG
0
µM
---Substrates
3PG
900
µM
Teusink et al, 2000
2PG
120
µM
Teusink et al, 2000
PEP
70
µM
Teusink et al, 2000
PYR
1850
µM
Teusink et al, 2000
KIN
354
µM
---PGI
14.22
µM
---6PFK
1.05
µM
---FBA
790
µM
---Enzyme
TPI
0.11
µM
---Concentrations
GAD
250
µM
---Used to Fit Model
PGK
34
µM
---PGM
0.377
µM
---ENO
86.0
µM
---PYK
1.245
µM
---R0
0.0008
µM/s
---Reaction Rates
Used to Fit Model
R27
0.00799
µM/s
----
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Figure 96. Simulation from SimBiology model for the species glyceraldehyde-3phosphate and dihydroxyacetone phosphate. BioModel 64 had no simulations for these
species.

The values of the glycolysis enzymes and the reaction rates of Reaction 0 and
Reaction 27 were adjusted to fit the model to BioModel 71. The values that resulted in a
successful fit are found in Table XXXII. The best fit was determined by comparing each
glycolysis substrate simulation between BioModel 71 and the SimBiology model. Figure
97, Figure 98, and Figure 99 show how the simulations of BioModel 71 compare with the
simulations of the SimBiology model.

A

B

Figure 97. Simulations from (A) BioModel 71 and (B) SimBiology model for the species
dihydroxyacetone phosphate, fructose-1,6-bisphosphate, glucose-6-phosphate,
extracellular glucose, and pyruvate.
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Table XXXII. Initial substrate concentrations, enzyme concentrations, and reaction rates
used to compare the SimBiology model to BioModel 71.
Species
Value
Unit
Reference
GLC_ex
50000
µM
Helfert et al, 2001
GLC
34
µM
Helfert et al, 2001
G6P
2072
µM
Helfert et al, 2001
F6P
512
µM
Helfert et al, 2001
FBP
16537
µM
Helfert et al, 2001
Initial
GAP
39.9
µM
Helfert et al, 2001
Concentrations
DHAP
3899
µM
Helfert et al, 2001
of Glycolysis
DPG
32.7
µM
Helfert et al, 2001
Substrates
3PG
0
µM
---2PG
0
µM
---PEP
0
µM
Helfert et al, 2001
PYR
4774
µM
Helfert et al, 2001
KIN
1200
µM
---PGI
78.5
µM
---6PFK
0.805
µM
---FBA
724.23
µM
---Enzyme
TPI
0.1059
µM
---Concentrations
GAD
309.5
µM
---Used to Fit Model
PGK
5.919
µM
---PGM
0.3977
µM
---ENO
87.1
µM
---PYK
1.2015
µM
---R0
0.01
µM/s
---Reaction Rates
Used to Fit Model
R27
0.01846
µM/s
----

A

B

Figure 98. Simulations from (A) BioModel 71 and (B) SimBiology model for the species
3-phosphoglycerate, fructose-6-phosphate, and phosphoenolpyruvate.
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A

B

Figure 99. Simulations from (A) BioModel 71 and (B) SimBiology model for the species
1,3-diphosphoglycerate, intracellular glucose, and glyceraldehyde-3-phosphate.

BioModel 71 had no simulation available for 2-phosphoglycerate. The
SimBiology simulation of 2-phosphoglycerate was fitted to the average concentration
from the other BioModels. Figure 100 shows how the simulation matches the average
value of 0.62 mM for 2-phosphoglycerate.

Figure 100. Simulation from SimBiology model for the species 2-phosphoglycerate.
BioModel 71 had no simulations available for this species.
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BioModel 172 - Pritchard 2002 Glycolysis:
BioModel 172 is a model of S. cerevisiae glycolysis (Pritchard & Kell, 2002).
Similar to BioModel 64, this model does not simulate glycolytic oscillations in yeast.
BioModel 172 is a model for a continuous fed reactor. Initial species concentrations used
in BioModel 172 were also used in the SimBiology model and are shown in Table
XXXIII. Enzyme concentrations and reaction rates were varied in the SimBiology model
in order to find a successful fit to BioModel 172. The best fit came from the values in
Table XXXIII.
Comparison of species simulations between BioModel 172 and the SimBiology
model are shown in Figure 101, Figure 102, and Figure 103. These figures show closely
matched simulations for all 11 glycolysis species that BioModel 172 can simulate.

A

B

Figure 101. Simulations from (A) BioModel 172 and (B) SimBiology model for the
species fructose-1,6-bisphosphate, extracellular glucose, glucose-6-phosphate, and
pyruvate.
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A

B

Figure 102. Simulations from (A) BioModel 172 and (B) SimBiology model for the
species fructose-6-phosphate, intracellular glucose, 2-phosphoglycerate, and 3phosphoglycerate.

A

B

Figure 103. Simulations from (A) BioModel 172 and (B) SimBiology model for the
species glyceraldehyde-3-phosphate, 1,3-diphosphoglycerate, and phosphoenolpyruvate.

BioModel 172 had no simulation available for dihydroxyacetone phosphate. The
simulation for dihydroxyacetone phosphate in the SimBiology model was matched to an
average concentration from other BioModels. BioModels 176 and 177 had an average
concentration of 0.785 mM for dihydroxyacetone phosphate. Figure 104 shows the
SimBiology simulation of dihydroxyacetone phosphate to be close to this value.
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Table XXXIII. Initial substrate concentrations, enzyme concentrations, and reaction rates
used to compare the SimBiology model to BioModel 172.
Species
Value
Unit
Reference
GLC_ex
2000
µM
Pritchard & Kell, 2002
GLC
97.7
µM
Pritchard & Kell, 2002
G6P
2675
µM
Pritchard & Kell, 2002
F6P
625
µM
Pritchard & Kell, 2002
FBP
6221
µM
Pritchard & Kell, 2002
Initial
GAP
45.2
µM
Pritchard & Kell, 2002
Concentrations
DHAP
0
µM
---of Glycolysis
DPG
0.74
µM
Pritchard & Kell, 2002
Substrates
3PG
886
µM
Pritchard & Kell, 2002
2PG
128
µM
Pritchard & Kell, 2002
PEP
63
µM
Pritchard & Kell, 2002
PYR
1815
µM
Pritchard & Kell, 2002
KIN
207.4
µM
---PGI
40.0
µM
---6PFK
0.835
µM
---FBA
417.2
µM
---Enzyme
TPI
0.105
µM
---Concentrations
GAD
133.4
µM
---Used to Fit Model
PGK
63.9
µM
---PGM
0.241
µM
---ENO
58.0
µM
---PYK
1.11
µM
---R0
0.01
µM/s
---Reaction Rates
Used to Fit Model
R27
0.0242
µM/s
----

Figure 104. Simulation from SimBiology model for the species dihydroxyacetone
phosphate. BioModel 172 had no simulations available for this species.
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BioModel 176 - Conant 2007 WGD Glycolysis 2A3AB:
BioModel 176 is also a simulation of glycolysis in the species S. cerevisiae
(Conant & Wolfe, 2007). This BioModel is based on a continuous fed reactor and does
not model glycolytic oscillations in yeast. Table XXXIV shows the initial species
concentrations from BioModel 176 that were also used in the SimBiology model. The
best fit to BioModel 176 was achieved by adjusting the twelve variables shown in Table
XXXIV until the SimBiology simulations matched the simulations from BioModel 176.
BioModel 176 had simulations available for all of the glycolysis species. The best
fit to BioModel 176 used the values found in Table XXXIV for the enzyme
concentrations and reaction rates. The simulations from this best fit are shown next to the
simulations from BioModel 176 in Figure 105 and Figure 106.

A

B

Figure 105. Simulations from (A) BioModel 176 and (B) SimBiology model for the
species glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate,
dihydroxyacetone phosphate, 3-phosphoglycerate, and pyruvate.
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A

B

Figure 106. Simulations from (A) BioModel 176 and (B) SimBiology model for the
species intracellular glucose, glyceraldehyde-3-phosphate, 1,3-diphosphoglycerate, 2phosphoglycerate, and phosphoenolpyruvate.

Table XXXIV. Initial substrate concentrations, enzyme concentrations, and reaction rates
used to compare the SimBiology model to BioModel 176.
Species
Value
Unit
Reference
GLC_ex
50000
µM
Conant & Wolfe, 2007
GLC
97.7
µM
Conant & Wolfe, 2007
G6P
2675
µM
Conant & Wolfe, 2007
F6P
625
µM
Conant & Wolfe, 2007
FBP
6221
µM
Conant & Wolfe, 2007
Initial
GAP
45.2
µM
Conant & Wolfe, 2007
Concentrations
DHAP
1004
µM
Conant & Wolfe, 2007
of Glycolysis
DPG
0.74
µM
Conant & Wolfe, 2007
Substrates
3PG
886
µM
Conant & Wolfe, 2007
2PG
128
µM
Conant & Wolfe, 2007
PEP
63.2
µM
Conant & Wolfe, 2007
PYR
1815
µM
Conant & Wolfe, 2007
KIN
454.8
µM
----PGI
60
µM
----6PFK
0.79
µM
----FBA
0.744
µM
----Enzyme
TPI
0.2248
µM
----Concentrations
GAD
307.9
µM
----Used to Fit Model
PGK
23.45
µM
----PGM
0.3752
µM
----ENO
61.1
µM
----PYK
1.642
µM
----R0
0.001
µM/s
----Reaction Rates
Used to Fit Model
R27
0.0496
µM/s
-----
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BioModel 177 - Conant 2007 Glycolysis 2C:
BioModel 177 is based on the same study for S. cerevisiae as BioModel 176
(Conant & Wolfe, 2007). The main difference between models is that BioModel 177
includes acetyl-CoA synthesis from pyruvate. This is the only glycolysis BioModel that
simulates acetyl-CoA. In order to fit simulations of acetyl-CoA to the BioModel,
Reaction 28 was added to account for acetyl-CoA that is used elsewhere in the cell.
Reaction 28 uses simple mass action kinetics, and the rate value was adjusted to achieve
the best fit to the simulations from BioModel 177.
Initial substrate concentrations in the SimBiology model were set equal to initial
concentrations used in BioModel 177. These values are shown in Table XXXV. The best
fit to BioModel 177 was found by varying the values for the ten glycolysis enzymes and
the three reaction rates for Reaction 0, Reaction 27, and Reaction 28. The values that
resulted in the best fit are shown in Table XXXV.
Simulations for each glycolysis substrate and acetyl-CoA were compared between
the SimBiology model and BioModel 177. The simulation values of acetyl-CoA,
pyruvate, and fructose-1,6-bisphosphate were very similar between the models as shown
in Figure 107. Comparable values were seen between the models for the rest of the
species as shown in Figure 108, Figure 109, and Figure 110.

Target Values in Glycolysis for the SimBiology Model:
Comparisons with the seven glycolysis BioModels resulted in a distribution of
enzyme concentrations, reaction rates, and initial species concentrations that could be
used in the final SimBiology model. Figure 111 shows box plots representing the range
of values used for the initial species concentrations in glycolysis. Ten outliers out of 84
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values were identified in these box plots. Outliers were removed and then an average
value was calculated for each species. Table XXXVI shows the resulting averages that
were used in the final SimBiology model for initial species concentrations.
The distribution of rate values for Reaction 0 and Reaction 27 are shown by the
box plots in Figure 112. One outlier out of 14 values was identified and removed before
average values were calculated. Table XXXVI shows the resulting averages that were
used as reaction rates in the final SimBiology model.

Table XXXV. Initial substrate concentrations, enzyme concentrations, and reaction rates
used to compare the SimBiology model to BioModel 177.
Species
Value
Unit
Reference
GLC_ex
50000
µM
Conant & Wolfe, 2007
GLC
97.7
µM
Conant & Wolfe, 2007
G6P
2675
µM
Conant & Wolfe, 2007
F6P
625
µM
Conant & Wolfe, 2007
FBP
6221
µM
Conant & Wolfe, 2007
Initial
GAP
45.2
µM
Conant & Wolfe, 2007
Concentrations
DHAP
1004
µM
Conant & Wolfe, 2007
of Glycolysis
DPG
0.74
µM
Conant & Wolfe, 2007
Substrates
3PG
886
µM
Conant & Wolfe, 2007
2PG
128
µM
Conant & Wolfe, 2007
PEP
63.2
µM
Conant & Wolfe, 2007
PYR
1815
µM
Conant & Wolfe, 2007
KIN
90.0
µM
----PGI
31.8
µM
----6PFK
0.69
µM
----FBA
415.9
µM
----Enzyme
TPI
0.161
µM
----Concentrations
GAD
159.0
µM
----Used to Fit Model
PGK
58.0
µM
----PGM
0.2298
µM
----ENO
50.01
µM
----PYK
1.12
µM
----R0
0.0005
µM/s
----Reaction Rates
R27
0.0264
µM/s
----Used to Fit Model
R28
0.00521
µM/s
-----
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A

B

Figure 107. Simulations from (A) BioModel 177 and (B) SimBiology model for the
species fructose-1,6-bisphosphate, pyruvate, and acetyl-CoA.

A

B

Figure 108. Simulations from (A) BioModel 177 and (B) SimBiology model for the
species intracellular glucose, glucose-6-phosphate, fructose-6-phosphate,
dihydroxyacetone phosphate, and 3-phosphoglycerate.

A

B

Figure 109. Simulations from (A) BioModel 177 and (B) SimBiology model for the
species 1,3-diphosphoglycerate, 2-phosphoglycerate, and phosphoenolpyruvate.
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A

B

Figure 110. Simulations from (A) BioModel 177 and (B) SimBiology model for the
species glyceraldehyde-3-phosphate.

A

B

C

Figure 111. Box plots showing the distribution of initial values for (A) glucose,
glyceraldehyde-3-phosphate, 1,3-diphosphateglycerate, 2-phosphoglycerate,
phosphoenolpyruvate, (B) glucose-6-phosphate, fructose-1,6-bisphophate,
dihydroxyacetone phosphate, pyruvate, (C) fructose 6-phosphate, and 3-phosphoglycerate
used in the glycolysis BioModels. Ten outliers out of 84 values were identified.
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A

B

Figure 112. Box plots showing the distribution of rates for (A) Reaction 0 and (B)
Reaction 27 used to fit the seven glycolysis BioModels. One outlier out of 14 values was
identified from these box plots.

Table XXXVI. Initial substrate concentrations, target enzyme concentrations, and
reaction rates used for the final model based on the seven glycolysis BioModels. Values
are averages of the seven BioModels once outliers have been removed.
Species
Value
Unit
GLC
70.9
µM
G6P
2619
µM
F6P
594
µM
FBP
5763
µM
Initial
GAP
43.9
µM
Concentrations
DHAP
2214
µM
of Glycolysis
DPG
7.0
µM
Substrates
3PG
890
µM
2PG
126
µM
PEP
59.9
µM
PYR
2012
µM
KIN
288
µM
PGI
46
µM
6PFK
0.72
µM
FBA
538
µM
Target Enzyme
TPI
0.26
µM
Concentrations
GAD
252
µM
for Final Model
PGK
32
µM
PGM
0.82
µM
ENO
169
µM
PYK
1.47
µM
R0
0.006
µM
Reaction Rates
R27
0.0248
µM
in Final Model
R28
0.00521
µM
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Distributions of the glycolysis enzyme values are shown in the box plots in Figure
113. Seven outliers out of 70 values were identified in the box plots. The outliers were
removed, and then average enzyme values were calculated. The average enzyme values
are shown in Table XXXVI and were used as target values in the model.

A

B

C

Figure 113. Box plots showing the distribution of values for the enzymes (A) kinase,
fructose-bisphosphate aldolase, glyceraldehyde-3-phosphate dehydrogenase, enolase (B)
6-phosphofructokinase, triose phosphate isomerase, phosphoglycerate mutase, pyruvate
kinase (C) phosphoglucose isomerase, and phosphoglycerate kinase used to fit the seven
glycolysis BioModels. Seven outliers out of 70 values were identified in these box plots.

Due to the presence of the transcriptional network, enzyme concentrations were
not held constant in the final model. Initial enzyme concentrations in the final model
were set equal to the values in Table XXXVI. Enzyme concentrations during the
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simulation are combination of the synthesis and degradation of the enzymes. Each
enzyme was monitored during simulations, and then promoter activity and enzyme
degradation rates were adjusted in order to achieve enzyme concentrations close to the
target values shown in Table XXXVI.

TCA Cycle BioModels:
The BioModels 222 and 232 were used to validate the TCA cycle in the predictive
model. The online simulator in the BioModels database was used to create simulations of
the substrates in the TCA cycle. Values in the SimBiology model were adjusted to mimic
the simulations of each BioModel.
The BioModels 222 and 232 do not account for glycolysis, acetyl-CoA synthesis,
or PHB synthesis. In the SimBiology model, these four pathways were shut off by
inactivating the forward and reverse directions of Reaction 1, Reaction 13, Reaction 14,
and Reaction 26. The concentration of each enzyme was held constant in order to
inactivate the transcriptional network portion of the model. The concentration of acetylCoA was held constant in both BioModels and in the SimBiology model. The
concentrations of CoA, ATP, ADP, NAD+, and NADH were also held constant during
simulation. Initial concentrations of substrates in the TCA cycle were changed to match
the initial values used in each BioModel. The values for TCA cycle enzyme
concentrations were adjusted until the SimBiology simulations matched the simulations
from the BioModel.
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BioModel 222 - Singh 2006 TCA Cycle:
BioModel 222 is the only BioModel that simulates the TCA cycle in E. coli
(Singh & Ghosh, 2006). BioModel 222 includes the glyoxylate bypass in the TCA cycle
and has simulations available for ten species in the TCA cycle. BioModel 222 held
acetyl-CoA constant during simulations, so acetyl-CoA was also held constant in the
SimBiology model. Initial species concentrations in the SimBiology model were set equal
to the values used in BioModel 222 that are shown in Table XXXVII. A best fit was
determined by adjusting the TCA cycle enzyme concentrations and comparing
simulations.

Table XXXVII. Initial substrate concentrations and enzyme concentrations used to
compare the SimBiology model to BioModel 222.
Species
Value
Unit
Reference
Ac-CoA
500
µM
Singh & Ghosh, 2006
OAA
4
µM
Singh & Ghosh, 2006
CIT
3000
µM
Singh & Ghosh, 2006
ISO
18
µM
Singh & Ghosh, 2006
Initial
2-OXO
200
µM
Singh & Ghosh, 2006
Concentrations of
SCA
40
µM
Singh & Ghosh, 2006
TCA Substrates
SUC
600
µM
Singh & Ghosh, 2006
FUMA
300
µM
Singh & Ghosh, 2006
MAL
1800
µM
Singh & Ghosh, 2006
GLY
4000
µM
Singh & Ghosh, 2006
CS
28.0
µM
----CHL
1800
µM
----ICHL
10.0
µM
----ICDH
0.3
µM
----OGDH
25770
µM
----Enzyme
SCS
7.0E-6
µM
----Concentrations
SDH
6.5
µM
----Used to Fit Model
FUM
0.1165
µM
----MDH
3.7
µM
----IL
0.1
µM
----MS
10
µM
-----
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Simulations for each TCA cycle species closely matched the simulations from
BioModel 222 when the enzyme concentrations in Table XXXVII were used. Figure 114
visually compares the values for acetyl-CoA, malate, fumarate, succinyl-CoA, and
succinate between BioModel 222 and the SimBiology model. Figure 115 illustrates the
closely matched values for oxaloacetate, 2-oxoglutarate, and isocitrate between the two
models. Figure 116 shows the comparison between the last two species: citrate and
glyoxylate.

A

B

Figure 114. Simulations from (A) BioModel 222 and (B) SimBiology model for the
species acetyl-CoA, succinyl-CoA, succinate, fumarate, and malate.

A

B

Figure 115. Simulations from (A) BioModel 222 and (B) SimBiology model for the
species oxaloacetate, isocitrate, and 2-oxoglutarate.
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A

B

Figure 116. Simulations from (A) BioModel 222 and (B) SimBiology model for the
species citrate and glyoxylate.
BioModel 232 - Nazaret 2009 TCA Cycle:
BioModel 232 was the only other BioModel found for the TCA cycle. The model
simulates the TCA cycle in Homo sapiens (Nazaret et al, 2009). This BioModel was not
the most desirable to use because it does not model the TCA cycle in a microorganism
and it only simulates four of the TCA cycle species. BioModel 232 also does not include
the glyoxylate bypass. However, since only two BioModels simulate the TCA cycle, it
was decided to try and fit the SimBiology model to BioModel 232. Table XXXVIII
shows the initial species concentrations used in BioModel 232 that were also used in the
SimBiology model. BioModel 232 did not have initial values for five of the TCA cycle
species, so initial values from BioModel 222 were used.
The TCA cycle enzyme concentrations were varied in the SimBiology model in
order to find the best fit to BioModel 232. The values of isocitrate lyase and malate
synthase were automatically set to zero since BioModel 232 did not include the
glyoxylate bypass. However, only three of the enzymes could be confidently adjusted and
fit to BioModel 232 since the model only had simulations available for acetyl-CoA,

124
oxaloacetate, citrate, and 2-oxoglutarate. Table XXXVIII shows the values used to fit the
SimBiology model to BioModel 232. The values for citrate synthase, citrate hydro-lyase,
and 2-oxoglutarate dehydrogenase were the key to matching the simulations of the four
TCA cycle species between models. Figure 117 illustrates the fit between the SimBiology
model and BioModel 232 based on four of the TCA cycle species.

Table XXXVIII. Initial substrate concentrations and enzyme concentrations used to
compare the SimBiology model to BioModel 232.
Species
Value
Unit
Reference
Ac-CoA
63
µM
Nazaret et al, 2009
OAA
5
µM
Nazaret et al, 2009
CIT
440
µM
Nazaret et al, 2009
Initial
ISO
18
µM
Singh & Ghosh, 2006
Concentrations
2-OXO
225
µM
Nazaret et al, 2009
of TCA
SCA
40
µM
Singh & Ghosh, 2006
Substrates
SUC
600
µM
Singh & Ghosh, 2006
FUMA
300
µM
Singh & Ghosh, 2006
MAL
1800
µM
Singh & Ghosh, 2006
CS
18.0
µM
----CHL
44.5
µM
----ICHL
1.0
µM
----ICDH
1.0
µM
----Enzyme
OGDH
1770.4
µM
----Concentrations
SCS
50.0
µM
----Used to Fit
SDH
50.0
µM
----Model
FUM
50.0
µM
----MDH
50.0
µM
----IL
0
µM
----MS
0
µM
-----

Target Values in the TCA Cycle for the SimBiology Model:
For the final SimBiology model, it was decided to use the initial species
concentrations in Table XXXVII that were used in BioModel 222. These values were
chosen because BioModel 222 was specifically for E. coli and had values for each TCA
cycle species. Initial enzyme concentrations were set to the values in Table XXXVII. In
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the final model, promoter activity and enzyme degradation rates were adjusted to
simulate enzyme concentrations consistent with the target values in Table XXXVII.

A

B

Figure 117. Simulations from (A) BioModel 232 and (B) SimBiology model for the
species acetyl-CoA, 2-oxoglutarate, citrate, and oxaloacetate.

Comparing Model with Experimental Data

No BioModels were available for the synthesis of PHB. The PHB synthesis
pathway in the model was validated using experimental data for PHB production. Table
XXXIX contains preliminary experimental PHB production data for two strains of E.
coli. Each strain contains the genes for the PHB synthesis pathway, but they are carried in
different plasmids. The SimBiology model was built specifically for E. coli carrying the
pBHR68 plasmid. The data for the 4MHT plasmid was included to demonstrate that the
predictive model is capable of being fitted to a specific strain of bacteria.
The enzymes in the PHB synthesis pathway (PhaA, PhaB, and PhaC) were held
constant in order to fit the model to the data. Different enzyme concentrations were tried
until the simulated PHB closely matched the PHB production data. Figure 118 shows the
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simulations that best fit the PHB production data for the two strains. Table XL shows the
enzyme concentrations used to achieve these two fits.

Table XXXIX. Experimental data for PHB production in E. coli strains containing 4MHT
or pBHR68 plasmids.
Strain
Time (hrs)
PHB (g/L)
8
0.0066
12
0.0262
4MHT*
24
0.4406
48
0.4609
8
Not detected
12
0.0348
pBHR68
24
0.0604
48
0.1120
*Plasmid 4MHT consists of the pBHR68 genes, the phasin
gene phaP1, and the membrane protein gene hlyA.

A

B

Figure 118. Simulated PHB fit to the PHB production data from the E. coli strains with
(A) the 4MHT plasmid and (B) the pBHR68 plasmid.

In the final SimBiology model, the enzyme values were not held constant.
Promoter activity and enzyme degradation rates were adjusted to generate the desired
enzyme concentrations. The concentrations in Table XL for the pBHR68 data were the
target values used since the model was created for the pBHR68 strain. Experimental data
from metabolic profiling can be used in the same way as the PHB production data. A
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better predictive model for a specific microorganism can be created by fitting the model
to more experimental data from that specific strain. A tutorial on how to download and
use the final model is available in Appendix D.

Table XL. Enzyme concentrations used to fit the model to experimental PHB production
data.
Strain
Enzyme
Concentration (µM)
PhaA
110
4MHT
PhaB
3
PhaC
5
PhaA
1.3
PhaB
0.41
pBHR68
PhaC
0.5
*Plasmid 4MHT consists of the pBHR68 genes, the phasin
gene phaP1, and the membrane protein gene hlyA.

Model Optimization and Results

The final SimBiology model was used to identify target genes and promoters for
genetic engineering. In the model, the value Km is a quantitative measure of the binding
affinity an enzyme has with its substrate. Lower values of Km represent higher substrate
affinity while higher values of Km represent lower substrate affinity. An enzyme’s
substrate affinity is dependent upon the amino acids that interact with the substrate in the
enzyme’s active site. These amino acids can be identified in the gene and then sitedirected mutagenesis can be used to change one or more of these amino acids. Changing
the amino acids of the active site can increase or decrease the enzyme’s substrate affinity
depending upon the new amino acids used. However, it is easier to make an enzyme less
effective at binding a substrate than trying to make it more effective.
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In the final SimBiology model, Km values for each enzyme were adjusted and
simulations were conducted to determine if the changes resulted in an increase in PHB
production. Adjusting the Km values resulted in no visible increase in PHB production for
16 enzymes, a slight increase in PHB production for 5 enzymes, and a large increase in
PHB production for 9 enzymes.
The transcriptional network portion of the model was also adjusted to optimize
the model for increased PHB production. Most promoters, transcription factors, and
ligands were not adjusted for optimization because of their wide use in metabolic
pathways not included in the model. Adjustments were conducted on the transcriptional
network directly associated with the pBHR68 plasmid that encodes the genes of the PHB
synthesis pathway.

Adjusting Enzyme Substrate Affinity:
The Km values for each of the 30 enzymes in this model were increased up to five
times or decreased down to a fifth of the original value. These values were used to
standardize comparisons of increased PHB production between enzymes. This is roughly
the same as making the enzyme active site five times less effective at binding the
substrate or five times more effective at binding the substrate. The direction of
adjustment that resulted in an increase in PHB production was the simulation kept for
comparison. Simulations were compared between enzymes to determine which
adjustments resulted in the greatest increase in PHB production.

PHB Synthesis Enzymes:
Decreasing the Km value for β-ketothiolase (PhaA) increased the PHB production
as shown in Figure 119. Decreasing the Km by one-fifth resulted in a 35.3% increase in
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PHB production. If β-ketothiolase has a better binding affinity then it results in higher
synthesis of PHB.
The enzyme acetoacetyl-CoA reductase (PhaB) has a Km value for the substrate
acetoacetyl-CoA and the substrate NADPH. A five-fold decrease in the Km value for
acetoacetyl-CoA resulted in a 1.0% increase in the rate of PHB production, and
decreasing the Km for NADPH by a fifth resulted in a 7.6% increase in the rate of PHB
production as seen Figure 120. By decreasing both Km values, an 8.6% increase in the
rate of production was observed as seen in Figure 121.

Figure 119. PHB production levels from adjusting PhaA’s Km for acetyl-CoA.

A

B

Figure 120. PHB production levels from adjusting PhaB’s Km for (A) acetoacetyl-CoA
and (B) NADPH.
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The enzyme PHB synthase (PhaC) has a Km value for the substrate 3hydroxybutyryl-CoA. Adjusting the Km value resulted in no visible change in the
production of PHB. Figure 122 shows the lack of change in PHB production when
compared to the original simulation. Out of the three PHB synthesis enzymes, adjusting
β-ketothiolase resulted in the largest increase in total PHB production.

Figure 121. PHB production levels from adjusting PhaB’s Km for acetoacetyl-CoA and
NADPH.

Figure 122. PHB production levels from adjusting PhaC’s Km for 3-hydroxybutyryl-CoA.
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TCA Cycle Enzymes:
Citrate synthase has a Km value for oxaloacetate and acetyl-CoA. Increasing the
Km for oxaloacetate by five fold resulted in 30.3% increase in PHB production as seen in
Figure 123. Multiplying the Km for acetyl-CoA by five resulted in an 87.7% increase in
PHB production as seen in Figure 123. A large 113.7% increase in PHB production was
observed by increasing both Km values by five times their original values as seen in
Figure 124.

A

B

Figure 123. PHB production levels from adjusting citrate synthase’s Km for (A)
oxaloacetate and (B) acetyl-CoA.

Figure 124. PHB production levels from adjusting citrate synthase’s Km for oxaloacetate
and acetyl-CoA.
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Adjusting the Km value for citrate hydro-lyase resulted in no visible increase in
the production of PHB. Increasing the Km value for the enzyme isocitrate hydro-lyase
resulted in a very slight increase in PHB production. The simulations for these two
enzymes can be found in Appendix C.
Adjusting the substrate affinity for isocitrate dehydrogenase yielded a visible
change in the amount of PHB synthesized. Decreasing the enzyme’s Km for isocitrate by
one fifth resulted in a 7.8% increase in PHB production as shown in Figure 125. Altering
the Km for the enzyme 2-oxoglutarate dehydrogenase had no visible effect upon the
synthesis of PHB. The simulation from adjusting the Km of 2-oxoglutarate dehydrogenase
is found in Appendix C.

Figure 125. PHB production levels from adjusting isocitrate dehydrogenase’s Km for
isocitrate.

The enzyme succinyl-CoA synthetase catalyzed the only reaction not modeled
using a kinetic mechanism. The reaction rate was adjusted in place of a Km value.
Increasing the rate of reaction for succinyl-CoA synthetase resulted in a barely noticeable
increase in PHB production. This simulation is included in Appendix C.
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Adjusting the Km values for the enzymes succinate dehydrogenase, fumarase, and
malate dehydrogenase resulted in no visible increase in PHB production. The simulations
for these enzymes are included in Appendix C.

Glyoxylate Bypass Enzymes:
Increasing the Km for the enzyme isocitrate lyase resulted in an 8.6% increase in
the synthesis of PHB as shown in Figure 126. For the enzyme malate synthase, no change
in PHB production was observed from adjusting the Km for glyoxylate and a very slight
increase in PHB production was observed from increasing the Km for acetyl-CoA. The
two simulations for malate synthase are included in Appendix C.

Figure 126. PHB production levels from adjusting isocitrate lyase’s Km for isocitrate.
Glycolysis Enzymes:
Altering the Km values for the enzymes kinase, phosphoglucose isomerase, and 6phosphofructokinase resulted in no visible increase in the production of PHB. The
simulations for these enzymes are found in Appendix C. Increasing the Km by five fold
for the enzyme fructose-bisphosphate aldolase resulted in a 22.5% increase in PHB
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production as seen in Figure 127. For the enzyme triose phosphate isomerase, multiplying
the Km value by five resulted in a 7.1% increase in PHB synthesis as seen in Figure 128.

Figure 127. PHB production levels from adjusting fructose-bisphosphate aldolase’s Km
for fructose-1,6-bisphosphate.

Figure 128. PHB production levels from adjusting triose phosphate isomerase’s Km for
dihydroxyacetone phosphate.

The enzyme glyceraldehyde-3-phosphate dehydrogenase binds three substrates so
it has Km values for glyceraldehyde-3-phosphate, NAD+, and inorganic phosphate.
Adjusting the Km for glyceraldehyde-3-phosphate resulted in no visible increase in PHB
production and the simulation is included in Appendix C. An 8.6% increase in PHB
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synthesis was observed from increasing Km by five-fold for inorganic phosphate as
shown in Figure 129. Increasing the Km for NAD+ by five-fold resulted in a 37.6%
increase in the synthesis of PHB as seen in Figure 129. A total increase of 72.8% in PHB
production was observed by increasing all three Km values by five fold as shown in
Figure 130.

A

B

Figure 129. PHB production levels from adjusting glyceraldehyde-3-phosphate
dehydrogenase’s Km for (A) NAD+ and (B) inorganic phosphate.

Figure 130. PHB production levels from adjusting glyceraldehyde-3-phosphate
dehydrogenase’s Km for NAD+, glyceraldehyde-3-phosphate, and inorganic phosphate.
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No visible increase in PHB production was observed by altering the Km values for
the enzymes phosphoglycerate kinase, phosphoglycerate mutase, and enolase. The
enzyme pyruvate kinase has a Km for phosphoenolpyruvate and ADP. Increasing or
decreasing the Km for phosphoenolpyruvate resulted in no visible change in the
production of PHB. A very slight increase in PHB production was observed by increasing
the Km for ADP. The simulations for these four enzymes are available in Appendix C.
Acetyl-CoA Synthesis Enzymes:
The only enzyme in the acetyl-CoA synthesis pathway is the multienzyme
complex pyruvate dehydrogenase. Figure 131 shows that an increase in PHB production
is the result of decreasing the Km value for the substrate pyruvate. Decreasing Km by onefifth resulted in a 26.0% increase in the synthesis of PHB.

Figure 131. PHB production levels from adjusting pyruvate dehydrogenase’s Km for
pyruvate.

Enzyme Summary:
Large increases in PHB production were observed by adjusting the Km values for
β-ketothiolase, acetoacetyl-CoA reductase, citrate synthase, isocitrate dehydrogenase,
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isocitrate lyase, fructose-bisphosphate aldolase, triose phosphate isomerase,
glyceraldehyde-3-phosphate dehydrogenase, and pyruvate dehydrogenase. The enzyme
acetoacetyl-CoA reductase was the only enzyme where changes in Km increased the rate
of PHB production. The largest percent increase (113.7%) came from adjusting the Km
values for citrate synthase, and the second largest increase (72.8%) came from changing
the Km values for glyceraldehyde-3-phosphate dehydrogenase as seen in Table XLI.
Altering Km values resulted in a slight increase in PHB production for the
enzymes isocitrate hydro-lyase, succinyl-CoA synthetase, malate synthase,
phosphoglycerate mutase, and pyruvate kinase. The adjustment of Km values caused no
increase in PHB production for the enzymes PHB synthase, citrate hydro-lyase, 2oxoglutarate dehydrogenase, succinate dehydrogenase, fumarate, malate dehydrogenase,
kinase, phosphoglucose isomerase, 6-phosphofructokinase, phosphoglycerate kinase,
enolase, glucose-1-phosphatase, fructose-1,6-bisphosphatase, phosphoenolpyruvate
carboxykinase, and phosphoenolpyruvate synthetase.

Table XLI. Km adjustments leading to increased PHB production. Percent increase is
from increasing or decreasing Km by five-fold.
Enzyme
Km, A Km, B Km, C
% Increase
β-ketothiolase
NA
NA
35.3
↓
Acetoacetyl-CoA reductase
NA
8.6*
↓
↓
Citrate synthase
NA
113.7
↑
↑
Isocitrate dehydrogenase
NA
NA
7.8
↓
Isocitrate lyase
NA
NA
8.6
↑
Fructose-bisphosphate aldolase
NA
NA
22.5
↑
Triose phosphate isomerase
NA
NA
7.1
↑
Glyceraldehyde-3-phosphate dehydrogenase
72.8
↑
↑
↑
Pyruvate dehydrogenase
NA
NA
26.0
↓
*Increase in rate
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Adjusting Ligand Concentration:
The only ligand adjusted for optimization of PHB production was IPTG. The
ligand IPTG binds to the LacI repressor and prevents it from repressing transcription of
the PHB synthesis genes. Concentrations of other ligands and transcription factors were
not tested for optimization because they are widely used in metabolic pathways so the
model cannot account for all of the effects that such changes would have on the cell. No
significant increase in PHB production was observed from increasing or decreasing the
concentration of IPTG as shown in Figure 132.

Figure 132. PHB production levels from adjusting concentrations of IPTG.

Adjusting Promoter Activity:
The only promoter tested for model optimization was the lac promoter in the
pBHR68 plasmid that regulates transcription of the PHB synthesis genes. It is easier to
genetically engineer the plasmid than to genetically engineer promoters in the genome.
Also, promoters in the genome often regulate the transcription of multiple genes. This
model only accounts for a small number of genes, so it cannot accurately predict the
effect of altering a promoter in the genome.
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The lac promoter that regulates the PHB genes was adjusted to increase PHB
production because all the genes in the pBHR68 plasmid are accounted for in the model.
Multiplying the lac promoter activity (β) by a factor of five resulted in an 8.5% increase
in PHB production as seen in Figure 133. Also, maximum PHB production was reached
by 12 hours compared to the 43 hours observed at normal promoter activity. A factor of
five was used to standardize comparison with the increases observed from adjusting Km
values for the enzymes.

Figure 133. PHB production levels from adjusting activity (β) of the lac promoter in the
pBHR68 plasmid.

Optimized Model:
An optimized model for PHB production was created by increasing promoter
activity by five fold for the lac promoter and by increasing all Km values by five fold for
citrate synthase and glyceraldehyde-3-phosphate dehydrogenase. This optimized model
resulted in a 226.8% increase in PHB production achieved by 29 hours compared to 43
hours. Figure 134 shows the comparison between the optimized model and the normal
model. Altering the enzymes contributed mostly to the increase in total PHB production,
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while altering the promoter activity contributed mostly to the increase in the rate of PHB
production as illustrated by Figure 134.

Figure 134. Simulations showing the comparisons between PHB production levels from
the unaltered model; PHB production levels from increasing Km values for citrate
synthase and glyceraldehyde-3-phosphate dehydrogenase; PHB production levels from
increasing the pBHR68 lac promoter activity (β); and PHB production levels from
increasing the Km values of the two enzymes and increasing the pBHR68 lac promoter
activity (β).
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DISCUSSION AND FUTURE WORK

Discussion

The predictive model identified nine enzymes as potential targets for genetic
engineering in order to optimize the production of PHB. Four of the enzymes required
decreasing Km in order to increase PHB production. Lowering Km values is equivalent to
increasing an enzyme’s substrate affinity. Engineering an enzyme to have a higher
substrate affinity is a difficult task because enzymes have evolved to be efficient at
binding their substrates. It is easier to make an enzyme less effective at binding its
substrate. Increasing the Km values of five enzymes led to an increase in PHB production.
The active sites of these five enzymes could be engineered to be less effective at binding
their substrates. Therefore, the nine potential targets for genetic engineering was
narrowed down to five enzymes.
Out of the five enzymes, altering the Km for citrate synthase resulted in the largest
increase in PHB production. Due to the 113.7% increase observed by increasing Km by
five fold, citrate synthase is the first target gene for engineering. The two active sites in
citrate synthase could be genetically engineered to be less effective at binding the
substrates oxaloacetate and acetyl-CoA, and the result should enhance PHB production.
Out of the five enzymes identified as potential targets, increasing the Km of
glyceraldehyde-3-phosphate dehydrogenase caused the second largest increase observed
in PHB production. Glyceraldehyde-3-phosphate dehydrogenase is the second target gene
for engineering because of the 72.8% increase in PHB synthesis that resulted from
increasing the Km values by five fold. The three active sites for glyceraldehyde-3-
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phosphate, NAD+, and inorganic phosphate could be genetically engineered to be less
effective at binding the substrates, and the result should increase PHB production.
The lac promoter in the pBHR68 plasmid was the third target identified for
genetic engineering. Increasing the lac promoter activity by five times resulted in an
8.5% increase in total PHB production and a 275% increase in the rate of PHB
production. Genetically engineering the lac promoter in the pBHR68 plasmid to have
greater activity should result in a significant increase in the rate of PHB production. The
only other adjustment that resulted in an increase in the rate of PHB production was
decreasing the Km by a fifth for the enzyme acetoacetyl-CoA reductase. However, this
adjustment only resulted in an 8.6% increase in the rate of PHB production. Therefore,
the lac promoter in the pBHR68 plasmid was chosen as the third target for genetic
engineering.
The simulation that made adjustments for all three targets resulted in a 226.8%
increase in maximum PHB production and a 275% increase in the rate of PHB
production. Genetically engineering a strain of E. coli that can produce more PHB in a
shorter amount of time will help make commercial PHB production more cost effective.
An optimized strain should be achieved by altering the genes for citrate synthase (gltA)
and glyceraldehyde-3-phosphate dehydrogenase (gapA), and by modifying the lac
promoter in the pBHR68 plasmid.
Instead of genetically engineering citrate synthase and glyceraldehyde-3phosphate dehydrogenase to be less effective, substrate analogs could be used as
competitive inhibitors for the enzymes. For citrate synthase, the compound
carboxymethyl-CoA acts as an inhibitor of the transition state with a high binding
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affinity. Theoretically, carboxymethyl-CoA could be added to the bioreactor to inhibit
citrate synthase. For glyceraldehyde-3-phosphate dehydrogenase, adenosine analogs can
be used as tight-binding inhibitors of the NAD+ active site. Adding an adenosine analog
to the bioreactor should slow down the enzyme glyceraldehyde-3-phosphate
dehydrogenase.
One major disadvantage of adding a compound to the bioreactor is that the
compound could affect more than just the target enzyme. Carboxymethyl-CoA could
inhibit other reactions that use acetyl-CoA. Adenosine analogs could inhibit other
reactions that use NAD+. Adding compounds to the bioreactor also increases production
cost. Due to the cost and potential side effects of adding substrate analogs to the reactor,
it was decided to focus first on genetically engineering the enzymes to be less effective.
Flux balance analysis (FBA) has widely been used in genome-scale metabolic
models. However, a model based on FBA would not have been able to predict that
lowering the substrate affinity of citrate synthase or glyceraldehyde-3-phosphate
dehydrogenase would increase PHB production. FBA is limited to predicting how the
addition or deletion of gene affects a product’s flux. Deletion of citrate synthase or
glyceraldehyde-3-phosphate dehydrogenase would be undesirable because they are both
part of key energy pathways in the cell. Also, FBA would not have been able to
quantitatively predict how adjusting promoter activity would impact PHB production
because FBA does not account for a dynamic transcriptional network.
Certain strains of PHB producing bacteria have been genetically engineered to
secrete the produced PHB. Secreting PHB into the growth media can significantly reduce
the cost of downstream processing. The secretion pathway could be added to the model to
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predict how to optimize a PHB secreting strain of bacteria for greater PHB production.
Another way to reduce cost of PHB production is to use a waste material as the initial
substrate. Whey is a waste product from cheese production that contains lactose. Lactose
could be used instead of glucose in the growth medium. The model could be adjusted to
account for the catabolism of lactose instead of glucose.
The design process used to make a predictive model for PHB production can be
used to develop predictive models for other bioproducts. Useful bioproducts such as
biofuels, biomaterials, and biopharmaceuticals are continually being developed, but often
many years of research are required before commercial production becomes costeffective. Predictive models can be used to develop optimized strains of bacteria for
production of specific bioproducts. Predictive models should help reduce time and cost
needed to get useful bioproducts out on the market.

Future Work

Metabolic profiling can be used to more precisely fit a predictive model to a
specific strain of E. coli. Due to the lack of a functioning mass spectrometer, this
predictive model was not fitted to metabolic profiling data. This model is not as accurate
as it could be if it was fitted to real time data from the specific strain of E. coli. Further
work should be done to obtain metabolic profiling data to use in the model.
After the model has been fitted to metabolic profiling data, the model should be
optimized to verify that altering the effectiveness of citrate synthase, glyceraldehyde-3phosphate dehydrogenase, and the lac promoter in the pBHR68 plasmid will optimize
PHB production.
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After the target genes have been verified, they should be genetically engineered to
mimic the optimized model. The amino acids in the active sites of citrate synthase and
glyceraldehyde-3-phosphate dehydrogenase should be identified. One or more of the
amino acids should be exchanged with a less effective amino acid through site-directed
mutagenesis. This genetic engineering should result in enzymes that are less effective at
binding their substrates. The lac promoter in the pBHR68 plasmid should be altered to
more closely match the consensus sequence that binds RNA polymerase. This genetic
engineering should stabilize the RNA binding and increase the activity of the lac
promoter in the pBHR68 plasmid.
Once the strain of E. coli has been genetically engineered for optimized PHB
production, metabolic profiling should be conducted again. The predictive model should
then be fit to the new metabolic profiling data. By comparing the old model with the new
data, the accuracy of the first predictive model can be determined. The new predictive
model can then be optimized to identify new targets for genetic engineering. This
iterative process should be repeated until a fully optimized strain of E. coli for PHB
production has been genetically engineered.
The PHB predictive model designed in this project is limited to five metabolic
pathways and accounts for only a portion of the transcriptional network. These
limitations only allow the PHB predictive model to predict outcomes from modifying 30
genes, one promoter, and one ligand. However, in the future the data needed to build a
genome-scale kinetic model will become available (Jamshidi & Palsson, 2008). A
genome-scale kinetic model would account for all the metabolic pathways and would
include a full, dynamic transcriptional network. Such a model would be able to predict
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the outcomes of modifying any gene, promoter, transcription factor, or ligand. A genomescale kinetic model would be a valuable tool in genetically engineering optimized
organisms for the production of bioproducts.
The PHB predictive model developed in this project is a step towards one day
realizing a genome-scale kinetic model as shown in Table XLII. Although the data
needed to build a genome-scale kinetic model is not yet available, progress comes from
implementing ideas with the tools that exist today. Engineers need to build working
models with the data and technology currently available, and then the models can be
improved as new data and technologies are discovered.

Table XLII. Comparisons between the current PHB predictive model and a future
genome-scale kinetic model.
PHB Predictive Model Genome-Scale Model
Metabolic Pathways: 5
Transcriptional Network: Partial, dynamic
Predict Outcomes from Modifying: 30 genes
1 promoter
1 ligand
0 transcription factors

All
Full, dynamic
Any gene
Any promoter
Any ligand
Any transcription factor
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Appendix B. HPLC-MS Analytical Methods
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HPLC-MS Analytical Methods
Metabolic profiling samples can be analyzed for concentration of metabolites
using high performance liquid chromatography coupled with mass spectrometry (HPLCMS). Standards should be used to identify and analyze concentrations of glucose,
pyruvate, citrate, 2-oxoglutarate, succinate, fumarate, malate, oxaloacetate, and betahydroxybutyrate. Dilutions of the standards should be used to create a standard curve for
each compound.
Mass spectrometric analysis can be conducted on an Agilient 6130 single
quadropole mass spectrometer. High performance liquid chromatography can be
performed on an Agilent 1200 Series HPLC. Solvent A should be an aqueous buffer, and
Solvent B should be acetonitrile. Two methods could be used to separate desired
metabolites. Method 1 is a reversed-phase liquid chromatography utilizing a C18 column.
Method 2 is a hydrophilic interaction liquid chromatography utilizing an aminopropyl
column (Bajad et al, 2006).
Concentrations of the metabolites can be analyzed for each time sample utilizing
HPLC-MS. An independent two-sample student’s t-statistic test could then be used to
compare the differences in concentrations of the above-mentioned metabolites between
the strain containing the PHB producing plasmid and the control to determine if the
addition of the PHB synthesis pathway significantly alters the kinetics of glycolysis and
the TCA cycle.
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Appendix C. Simulations
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Figure 135. PHB production levels from adjusting (A) citrate hydro-lyase’s Km for
citrate, (B) isocitrate hydro-lyase’s Km for aconitate, (C) oxoglutarate dehydrogenase’s
Km for 2-oxoglutarate, (D) succinyl-CoA synthetase’s reaction rate, (E) succinate
dehydrogenase’s Km for succinate, and (F) fumarase’s Km for fumarate.
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Figure 136. PHB production levels from adjusting (A) malate dehydrogenase’s Km for
malate, (B) malate dehydrogenase’s Km for NAD+, (C) malate synthase’s Km for
glyoxylate, (D) malate synthase’s Km for acetyl-CoA, (E) kinase’s Km for glucose, and
(F) kinase’s Km for ATP.
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Figure 137. PHB production levels from adjusting (A) phosphoglucose isomerase’s Km
for glucose-6-phosphate, (B) phosphoglucose isomerase’s Km for fructose-6-phosphate,
(C) 6-phosphofructokinase’s Km for fructose-6-phosphate, (D) 6-phosphofructokinase’s
Km for ATP, (E) glyceraldehyde-3-phosphate dehydrogenase’s Km for glyceraldehyde-3phosphate, and (F) phosphoglycerate mutase’s Km for 3-phosphoglycerate.
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Figure 138. PHB production levels from adjusting (A) phosphoglycerate kinase’s Km for
1, 3-diphosphateglycerate, (B) phosphoglycerate kinase’s Km for ADP, (C) enolase’s Km
for 2-phosphoglycerate, (D) pyruvate kinase’s Km for phosphoenolpyruvate, and (E)
pyruvate kinase’s Km for ADP.
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Appendix D. SimBiology Model Tutorial
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Instructions are for SimBiology Version 3.2 (R2010a)
Download File
Predictive Model: http://digitalcommons.usu.edu/engineering_datasets/1/
Open SimBiology Project
Open MATLAB
Type “sbiodesktop” to open SimBiology
Go to File, then select Open Project, then select the Predictive Model
How to Open Diagram View:
In the Project Explorer window pane, expand Model Session, then expand
SimBiology Model and select Diagram View

Editing Properties of Species
Double-click on the Species block
Settings Tab
o Here changes can be made to the initial amount of the species
o Select whether the species is held constant, or if the amount is determined
by a boundary condition
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Editing Properties of Reactions
Double-click on the Reaction block
Settings
o Here changes can be made to the kinetic law and parameters
o Reaction rate expression can be edited by clicking on the pencil icon
o Km values can be changed by double-clicking the Value cell for Km and
entering a new value
o Make a reaction unactive during the simulation by unchecking the Active
checkbox
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Cloned/Split Species
o A block is cloned or split to separate a species that participates in multiple
reactions.
o Although there could be multiple split/clone blocks, there is only one species.
Changes made to any settings in the Species Properties dialog box will be
propagated to each of the split/clone blocks.

Parameter Properties
Changing a Parameter’s Scope:
o In the Project Explorer window pane select Parameters
o Right-click on the desired parameter in the Scope column. Select
“Change Parameter Scope.” This toggles the scope between the reaction
and the overall model. A parameter must have a global scope if it is used
in an Event or a Rule.
Constant:
o The default setting for all parameters is for them to be held constant
throughout the entire simulation. To change the parameters value partway
through the simulation (through use of an Event), then uncheck the
ConstantValue box in the parameter settings.
Rules
In the Project Explorer window pane select Rules
4 Types of Rules:
1. Algebraic — Evaluated continuously during a simulation
2. Initial Assignment — Evaluated once at the beginning of the
simulation
3. Repeated Assignment — Evaluated at every time-step of the
simulation
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4. Rate — Evaluated continuously during the simulation
Tip: To use a parameter in a rule, remember to set the Scope of the
parameter to “model.” To use an algebraic or rate rule to vary the
value of a parameter during the simulation, clear the ConstantValue
checkbox for the parameter in the Parameters pane. Also, if using a
rule to define a species concentration, clear the ConstantAmount
checkbox and check the BoundaryCondition checkbox.
Events
In the Project Explorer window pane select Events
Events are used to describe sudden changes in model behavior. An event can
specify discrete transitions in model component values that occur when a userspecified condition become true.
Uses:
To activate or deactivate certain species (activator or inhibitor species),
change parameter values, change reaction rates in response to addition or
removal of species
Trigger:
The trigger can be time-dependent or time-independent
Event Functions:
Event functions are the results when the event is turned on by the trigger
Active:
The Active check box must be marked for the event to work. To simulate the
model without the event, then clear the Active check box.
Tip:
To use a parameter in an event, remember to set the Scope of the parameter to
model and to clear the ConstantValue check box for the parameter in the
Parameters pane. Also, the solver must be set to sundial in order to simulate
events.
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Configuration Settings
In the Project Explorer window pane expand Model Session and select
Configuration Settings
Before running a simulation, use the Configuration Settings to set the simulation
time, solver, etc.
Custom Configuration Settings:
To store simulation settings for later use, type a name for the settings in
the Enter Name edit box, and click Add to create your custom
configuration settings. Any changes made in the Settings and Data
Logging tabs will be saved with the project.
Custom Configuration Settings Available in Predictive Model
o
o
o
o
o

CoFactor: Simulates cofactors in model
PHB synthesis: Simulates species in PHB synthesis pathway
TCA cycle: Simulates species in TCA and Glyoxylate pathways
Glycolysis: Simulates species in the Glycolysis pathway
Glucose_PHB: Simulates key species of the entire model

Settings:
o Set simulation time
o Choose solver (Use sundial if using Events)
o Select the species to be logged
Simulation
In the Project Explorer window pane expand Model Session, then expand
Model Tasks and select Simulation
o In the Settings tab, select the Configuration Settings to use for the
simulation
o Next, select the Plots tab
o Double click the “y” argument box to select which species to plot
o Under Plot Behavior, select if the simulation should be a new
figure or if it should be added to the current axes
o Click the Run icon in the main Toolbar
o A graph of your simulation will appear in the Figures window pane
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Importing Data
In the main task bar, select File, and then select Add Data, and choose From File
o Select a file to download
o Select if the first row contains header information
o Look at the Data Preview, and if it looks good, then click Okay
Plotting Multiple Simulations in a Single Figure
In the Project Explorer window pane expand Model Session, then expand
Model Tasks and select Simulation
o In the Plots tab, select whether the plot should be put in a new Figure or if
the plot should be added to the current axes. If “Add to current axes” is
selected then the simulation will be plotted on the Figure last selected.
This is the best way to overlay different simulations.
Plotting a Dataset with a Simulation in a Single Figure
In the Project Explorer window pane expand Model Session, then expand
Model Tasks and select Simulation
o In the Plots tab, select an XY Plot Type and click “Add Plot Type”
o For the first plot (Time Plot Type), choose the Plot Behavior “New
Figure”
o Double-click on the “y” argument to select which species to plot
from the simulation.
o For the second plot (XY Plot Type), choose the Plot Behavior “Add to
current axes”
o Double-click on the “x” argument to select the x-variable from the
imported dataset. Double-click on the “y” argument to select the yvariable from the imported dataset.
o As long as both Create Plot checkboxes are checked, a Figure will be
created containing the simulation and the dataset

